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Introduction 
The skull is one of the latest inventions of vertebrate evolution. It serves many very vital 
functions, like eating and defence. Moreover, it harbours the brain and many sense organs that 
are required for perception of the environment, e.g. for sight, smell, hearing and taste. In 
primates it has equipped the animal with a unique tool to express emotions. Unfortunately, the 
skull appears to be very susceptible to malformations. Many babies are born each year with 
craniofacial birth defects due to e.g. inappropriate development of the craniofacial primordia or 
due to abnormalities in neural tube development. Recent studies show that mutations in 
developmental genes appear to be the underlying cause of many of these birth defects.  
In this introduction I will discuss the embryonic origin of most of the skull bones and give an 
overview of craniofacial morphogenesis. Moreover, I will discuss the roles of a number of 
genes important in craniofacial development. The chapter will conclude with the discussion of 
a number of well-known craniofacial defects. 
 
The skull and its embryonic origins 
The skull is one of the most complicated parts of the vertebrate body. It has long stimulated 
questions as to how it is constructed and how it develops during ontogeny. Anatomically the 
skull can be divided into brain case and the facial skeleton. The braincase consists of the 
frontal, parietal and supraoccipital bones, which overlie and protect the brain. The skull base 
supports the brain and consists of exo- and basioccipital and sphenoid bones and the nasal 
capsule (=ethmoid bone) (see Fig. 1.1). The facial skeleton is constituted by the nasal bones, 
the premaxillary, maxillary, zygomatic and squamosal bones and the mandible. The nasal and 
otic capsules are sensory organs that develop from the otic and nasal placodes, respectively 
(see Fig. 1.1). 
A subdivision of the skull bones can also be made based upon their embryonic origin (Couly et 
al., 1993). The chordal skeleton consists of bones that are derived from cephalic and somitic 
mesoderm. The cephalic mesoderm surrounds the primitive brain vesicles and it condensates to 
form the supraoccipital bone, part of the otic capsule and the basisphenoid bones. On the other 
hand, mesoderm derived from the first five occipital somites forms the basi- and exooccipital 
bones and also some structures of the otic capsule (Couly et al., 1993).  
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The prechordal (or achordal) skeleton consists of bones that are derived from the cranial neural 
crest. The neural crest is a population of cells that detaches from the neural folds during neural 
tube closure and undergoes an epithelial to mesenchymal transition. The cells migrate away 
from the neural tube and populate many regions in the embryo to give rise to various tissues. 
The cranial neural crest is derived from fore- mid- and hindbrain regions. It contributes to 
formation of many structures like connective tissue, odontoblasts and neurons and glia of 
cranial ganglia. Moreover, it forms a significant part of the skull. The basipresphenoid and 
more anterior bones comprising the entire facial skeleton are entirely neural crest derived, but 
also a part of the otic capsule (Couly et al., 1993).  
The embryonic origin of the calvaria remains uncertain. Studies carried out by Couly et al. 
(1993) show that the frontal and parietal bones are neural crest derived, whereas other studies 
conclude that they are derived from cephalic mesoderm (Goodrich, 1930; LeLievre, 1978; 
Jarvik, 1980; de Beer, 1985; Noden, 1986). It should be kept in mind that all these studies were 
carried out using chick embryos, which are well accessible to tissue transplantation studies. 
However, the avian skull is considerably different from the mammalian skull and many 
structures along the neural crest:mesoderm interface are anatomically very different (e.g. 
vaults, palatine, sphenoid regions). Therefore, it is not clear if all avian data on the embryonic 
origins of certain skull bones can easily be extrapolated to the mammalian situation. A recently 
generated two component transgenic mouse line system, in which LacZ is expressed in the 
Wnt1 domain may shed more light on this issue (Chai et al., 2000). 
basipresphenoid 
Fig. 1.1: Anatomy of the mouse skull. Lateral view on the left. Dorsal view on cranial base with 
vaults and mandible removed on the right.  
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Craniofacial morphogenesis 
The face develops on the rostral end of the embryonic axis from the facial primordia that are 
arranged around the primitive mouth, the stomodeum. The primordia include the frontonasal 
process and the first branchial arch derived paired mandibular and maxillary processes (see Fig. 
1.4). The second, third, fourth and sixth arch will contribute to more posterior structures of the 
larynx and some thoracic blood vessels. Early during craniofacial development, the frontonasal 
process and the branchial arches are populated with paraxial mesoderm and cranial neural crest 
cells (reviewed by Noden, 1988; Köntges and Lumsden, 1996; Couly et al., 1996). 
 
The branchial arches  
The branchial arches develop as bulges surrounding the pharynx (see Fig. 1.2). Within the 
pharynx, they are lined with endoderm and their outer surface is covered with ectoderm. 
Branchial pouches and branchial grooves demarcate their borders on the inner and outer 
surface of the pharynx, respectively. In between the arches the branchial membranes are 
formed at the boundary between endo- and ectoderm. The branchial arches are populated by 
paraxial mesoderm and neural crest cells (Couly et al., 1993). The paraxial mesoderm forms 
the craniofacial muscles, some skeletal elements and vascular tissues, while cranial neural crest 
cells contributes to the peripheral nervous system, connective tissues and cartilage (Le 
Douarin, 1982; Noden, 1988; Kimmel et al., 1991; see Fig. 1.2). 
 
 
 
 
 
 
Fig. 1.2: Schematic view of pharynx and branchial arches. Every branchial gives rise to a basic set of 
structures: a cartilage component, a nervous component, a vascular component and a muscular 
component. 
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The first branchial (or mandibular) arch is populated by neural crest cells derived from the 
midbrain and the three most anterior rhombomeres (see Fig. 1.3). It develops into a mandibular 
and a maxillary portion. Within the mandibular portion Meckel’s cartilage is formed, which 
provides a template for subsequent development of the mandible. A substantial part of 
Meckels’s cartilage will be covered by bone, but more proximal elements persist as two ear 
ossicles, the malleus and the incus, while its anterior extremity persists as a cartilage element 
connecting both dentaries. The musculature associated with the first branchial arch includes the 
muscles of mastication, which are innervated by the trigeminal nerve. The maxillary process of 
the mandibular arch will give rise to the upper jaw and cheek region (see Table 1).  
The second branchial (or hyoid) arch is populated by rhombomere 3 and 4 derived neural crest 
cells (see Fig. 1.3). They condensate to form Reichert’s cartilage, most of which develops into 
the hyoid bone and stapes, the styloid process of the temporal bone and the stylohyoid 
ligament. The muscles formed by the second arch are the facial muscles, which are innervated 
by the facial nerve (see Table 1). 
The third branchial arch is populated by crest derived from rhombomere 5 and 6 and forms the 
greater cornu and the lower part of the hyoid bone. The glossopharyngeal nerve innervates the 
third arch (see Fig. 1.3 and Table 1). The laryngeal cartilages seem to be formed independently 
of the neural crest, as they most likely derive from lateral plate mesoderm residing in the fourth 
and sixth branchial arches (Noden, 1986 and references therein). Innervation is brought about 
by the vagus nerve (see Table 1). 
 
 
 
 
 
Di- and anterior mesencephalic NC 
Posterior mesencephalic NC 
Rhombomere 1 NC 
Rhombomere 2 NC 
Rhombomere 3 NC 
Rhombomere 4 NC 
Rhombomere 5 NC 
Rhombomere 6 NC 
Rhombomere 7 NC 
Fig 1.3: Cranial neural 
crest migration into the 
frontonasal process and the 
branchial arches. The 
origin of the neural crest in 
the frontonasal process and 
branchial arches is color-
coded.  Abbreviations: BA, 
branchial arch; FNP: 
frontonasal process; R: 
rhombomere, NC: neural 
crest (Figure from Le 
Douarin and Kalcheim, 
1999). 
FNP 
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The frontonasal process 
The frontonasal process is populated by neural crest cells derived from fore- and midbrain 
regions (Osumi-Yamashita et al., 1994; see Fig. 1.3). They give rise to the trabecular cartilage, 
which originally arises as a pair of bar-like cartilages. Later it develops into the premaxillary 
bones, the ethmoid (comprising the nasal capsule and the nasal septum) and the presphenoid 
bones. Also the frontal and nasal bones develop from the frontonasal process (Rathke, 1839; 
reviewed by de Beer, 1931, 1937; see Table 1). There are a few reasons that suggest that the 
trabecula may represent a "premandibular" component of the facial skeleton and belong to the 
same segment as the ophtalmic nerve. These are its neural crest origin, its topographical 
location, its morphology and the metamerical organization of cranial nerves (Huxley, 1874; 
reviewed by Goodrich, 1930; de Beer, 1931, 1937; Stadmüller, 1936; Kuratani, 1997).  
Chapter 1 
 
 12
 
M
u
sc
u
la
tu
re
 
 M
u
sc
le
s 
fo
r 
m
as
tic
at
io
n
 
M
yl
o
hy
o
id
 
A
sn
te
rio
r 
be
lly
 
o
f t
he
 
di
ga
st
ric
 
Te
n
so
r 
ty
m
pa
n
i 
Te
n
so
r 
pa
la
tin
i 
M
u
sc
le
s 
fo
r 
fa
ci
al
 
ex
pr
es
sio
n
 
Po
st
er
io
r 
be
lly
 
o
f d
ig
as
tr
ic
 
St
ap
ed
iu
s 
St
yl
o
hy
o
id
 
 In
tr
in
sic
 
m
u
sc
le
s 
o
f t
he
 
la
ry
n
x
 
V
a
sc
u
la
tu
re
 
 M
ax
ill
ar
y 
ar
te
rie
s 
St
ap
ed
ia
l a
rt
er
ie
s 
(in
 
em
br
yo
 
o
n
ly
) 
Co
m
m
o
n
 
an
d 
in
te
rn
al
 
ca
ro
tid
 
ar
te
rie
s 
Pa
rt
 
o
f a
du
lt 
ar
ch
 
o
f a
o
rt
a 
Pa
rt
 
o
f s
u
bc
la
v
ia
n
 
ar
te
ry
 
Pa
rt
 
o
f l
ef
t p
u
lm
o
n
ar
y 
ar
te
ry
 
D
u
ct
u
s 
ar
te
rio
su
s 
Pa
rt
 
o
f r
ig
ht
 
pu
lm
o
n
ar
y 
ar
te
ry
 
N
er
v
e 
O
ph
th
al
m
ic
 
br
an
ch
 
o
f 
tr
ig
em
in
al
 
n
er
v
e 
(V
) 
Tr
ig
em
in
al
 
(V
) 
Fa
ci
al
 
(V
II)
 
G
lo
ss
o
-
 
Ph
ar
yn
ge
al
 
(IX
) 
V
ag
u
s 
(X
) 
Sk
el
et
a
l e
le
m
en
ts
 
Tr
ab
ec
u
la
r 
ca
rt
ila
ge
s 
(tr
an
sie
n
t) 
Et
hm
o
id
 
(=
n
as
al
 
ca
ps
u
le
)  
N
as
al
 
bo
n
e 
 
Fr
o
n
ta
l b
o
n
e 
La
cr
ym
al
 
bo
n
e 
B
as
ip
re
sp
he
n
o
id
 
bo
n
e 
Pr
em
ax
ill
a 
M
ec
ke
ls’
 
ca
rt
ila
ge
 
(tr
an
sie
n
t) 
M
al
le
u
s 
In
cu
s 
M
an
di
bl
e 
M
ax
ill
a 
Zy
go
m
at
ic
 
ar
ch
 
Pa
la
tin
e 
A
lis
ph
en
o
id
 
Sq
u
am
o
sa
l 
R
ei
ch
er
t’s
 
ca
rt
ila
ge
 
(tr
an
sie
n
t) 
St
ap
es
 
St
yl
o
id
 
pr
o
ce
ss
 
Le
ss
er
 
co
rn
u
 
o
f h
yo
id
 
U
pp
er
 
pa
rt
 
o
f b
o
dy
 
hy
o
id
 
bo
n
e 
G
re
at
er
 
co
rn
u
 
o
f h
yo
id
 
Lo
w
er
 
pa
rt
 
o
f b
o
dy
 
o
f h
yo
id
 
bo
n
e 
Th
yr
o
id
,
 
Cr
ic
o
id
,
 
A
ry
th
en
o
id
,
 
Co
rn
ic
u
la
te
 
an
d 
Cu
n
ef
o
rm
 
ca
rt
ila
ge
s 
Ta
bl
e 
1:
 
St
ru
ct
u
re
s 
de
v
el
o
pi
n
g 
in
 
th
e 
br
a
n
ch
ia
l a
rc
he
s 
A
rc
h 
(0)
 
 
Pr
em
a
n
di
bu
la
r 
a
rc
h 
 1  
(M
a
n
di
bu
la
r 
a
rc
h)
 
 2  
(H
yo
id
 
a
rc
h)
 
3 4+
6 
 
Introduction 
 13
Development of the face 
Facial development starts with the emergence of the facial primordia, the branchial arches and 
the frontonasal process. They grow out by controlled proliferation of neural crest derived 
mesenchymal cells, which are dependent on signals from the overlying ectoderm (Wedden, 
1987; Richman and Tickle, 1992). The primordia undergo complex morphogenetic interactions 
and ultimately they a complete face. 
 
Development of lower and upper jaw and nose region 
The mandibular and maxillary processes of the first arch grow out and develop in a 
ventromedial direction (see Fig. 1.4A-D and Table 1). The mandibular processes fuse in the 
midline and eventually form the lower jaw. The maxillary processes of the first arch give rise 
to the upper jaw and cheek regions (see Fig. 1.4A-D and Table 1). Early during facial 
development the surface ectoderm on lateral regions of the frontonasal process thickens and 
forms the nasal placodes (see Fig 1.4A). Due to outgrowth of the frontonasal process the 
placodes deepen, resulting in formation of the lateral and medial nasal processes (see Fig. 1.4B, 
C). The nasal processes fuse inferiorly with each other and with the outgrowing maxillary 
processes to form the intermaxillary segment (see Fig. 1.4C). The intermaxillary segment will 
form the primary palate, premaxilla and philtrum (see Fig. 1.4C and D, Fig. 1.5A, B, C and 
Table 1). The nasolacrimal groove is the cleft, which separates the lateral nasal and maxillary 
processes (see Fig. 1.4C and D). 
 
. 
 
 
 
 
 
Fig. 1.4: Development of the lower and upper jaw and nose region. Frontal views on cranial regions 
of developing embryos. Abbreviations: 2nd: 2nd branchial arch, 3rd: 3rd branchial arch, FNP: 
frontonasal process, FP: frontal process, He: heart bulge, IMS, intermaxillary segment; LNP: lateral 
nasal process, Mn: Mandibular process, MNP: medial nasal process, Mx: maxillary process; NLG: 
nasolacrymal groove, Npi: nasal pit, NPl: nasal placode; Ph: philtrum, St: stomodeum. 
A B C D 
FNP 
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Mx 
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Mn 2nd 
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Development of secondary palate and internal nose structures 
From the inner walls of the maxillary arches palatal shelves grow out (see Fig. 1.5A). First they 
project vertically (Fig. 1.5D), but later they extend upward and fuse in the midline with each 
other. Anteriorly they fuse with the primary palate to form the secondary or definitive palate 
(see Fig. 1.5C, F). The nasal septum grows downwards from the frontal process and fuses with 
the palate (see Fig. 1.5D, E, F). The definitive palate physically separates nasal and oral 
cavities and the nasal septum separates both nasal cavities. The nasopalatine canal (incisive 
foramen) persists in the palatine midline between the premaxillary portion of the maxilla and 
the palatine processes of the maxilla (see Fig. 1.5C). Within the lateral walls of the nasal cavity 
the nasal conchae are formed and develop into the nasal labyrinth. 
 
 
 
 
 
 
Genes involved in craniofacial development 
Whilst a lot is known about origins of skull bones and craniofacial morphogenesis, relatively 
little is known about molecular mechanisms regulating craniofacial development. Craniofacial 
development is a multi-stage process. It involves the formation and migration of cranial neural 
crest cells, followed by the correct outgrowth of the facial primordia and the morphogenesis 
Fig. 1.5: Formation of definitive palate. A, B, C: ventral view maxilla. D, E, F: frontal section at the 
level of the nasal and oral cavities. Abbreviations: DP: definitive palate, FP: frontal process, IF: 
incisive foramen, Mx: maxilla, NC: nasal cavity, Nco: nasal conchae, NS: nasal septum, OC: oral 
cavity,  Ph: philtrum, PP: primary palate, PS: palatine shelf, T: tongue. 
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and differentiation of the skeletal elements. During these stages, members of many gene 
families are expressed and have functions in the (presumptive) neural crest cells and in the 
development of the craniofacial primordia (review by Francis-West, 1998).  
 
Genes involved in prepatterning of the cranial neural crest 
Before craniofacial development starts, members of different gene families regionalize the 
neural tube. They are responsible for the identity of neural crest cells that originate from these 
regions. However, prepatterning of the neural tube alone does not bring about specification of 
neural crest identity. Environmental signals, such as signals emitted from the branchial arches 
or the somites, are also important (Grapin-Botton et al., 1995; Itasaki et al., 1996; Grapin-
Botton et al., 1997; Hunt et al., 1998, Trainor and Krumlauf, 2000).  
 
Hox genes 
Hox genes are homeobox genes expressed from caudal neural tube regions up to a specific 
anterior border. The ’Hox-code’, which is the combination of Hox genes expressed within a 
certain body segment, determines its AP identity. The most anterior Hox genes are expressed 
up to hindbrain regions. Their overexpression or loss-of-function mutations cause craniofacial 
abnormalities (see Fig. 1.6). Hoxa1 and Hoxb1 are transiently expressed in rhombomeres 4 to 
6. Hoxa1 and Hoxb1 mutant mice display abnormalities in second branchial arch derivatives 
and the VIIth to XIth cranial nerves (Lufkin et al., 1991; Chisaka et al., 1992; Carpenter et al., 
1993; Dollé et al., 1993; Mark et al., 1993; Goddard et al., 1996; Studer et al., 1996, 1998; 
Gavalas et al., 1998). Hoxa2 is expressed in the developing hindbrain. In Hoxa2 mutant mice, 
the identity of cranial neural crest cells in the second branchial arch seems to have changed into 
a first branchial arch identity (Gendron-Maguire et al., 1993; Rijli et al., 1993). Hoxa3 is 
expressed up to the 5th rhombomere and mouse mutants display abnormalities in cartilages and 
bones of the jaw (Lufkin et al., 1991; Chisaka and Capecchi, 1991).  
 
Otx1, Otx2, Emx1, Emx2 and Gbx2 
The homeobox genes Otx1 and -2 and Emx1 and -2 are homologs of the Drosophila genes 
orthodenticle and empty spiracles, respectively. They are expressed in nested patterns in the 
fore- and midbrain territories indicative of the existence of a genetic code responsible for AP 
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patterning of these brain regions (see Fig. 1.6). Indeed, genetic analysis reveals a role for these 
genes in patterning these regions and craniofacial primordia. 
Otx2 is expressed in fore- and midbrain (see Fig. 1.6, Simeone et al., 1993; Ang et al., 1994). 
Inactivation or overexpression of Otx2 causes abnormalities of brain development (Matsuo et 
al., 1995; Acampora et al., 1995; Pannese et al., 1995; Ang et al., 1996). Otx2 heterozygous 
mutant mice display multiple skeletal defects in the prechordal skull. Homozygous Otx2 
mutant embryos die before E10.0 and lack structures corresponding to the rostral head (Matsuo 
et al., 1995). 
 
 
 
 
Otx1 is expressed in the more posterior forebrain regions and in the midbrain. Otx1 mutants 
display morphological transformation of fore- and midbrain regions into hindbrain (see Fig. 
1.6, Acampora et al., 1996). Moreover, Otx1 is capable to take over functions of Otx2 in 
patterning of the neural crest (Suda et al., 1999). Emx1 and Emx2 are expressed in overlapping 
patterns in the forebrain. Emx1 and Emx2 mutants display abnormalities in the telencephalic 
cortex (see Fig. 1.6, Qiu et al., 1996; Pellegrini et al., 1996; Yoshida et al., 1997).  
Gbx2 is expressed in regions of the anterior hindbrain with a sharp boundary at the mid-
/hindbrain border, marking the isthmic organizer (see Fig. 1.6). Gbx2 mutant mice display 
abnormal development of the anterior hindbrain and genetic markers of the isthmic organiser 
Gbx-2 
Hox-a2 
Hox-b1 
Hox-a3 
Hox-a1 
BA1 
BA2 
BA3 
BA4-BA5 
Fig. 1.6: Genes that are involved in regionalization of the  fore-, hind- and midbrain regions and 
determination of neural crest identity.  
R1 R2 R3 R4 R5 R6 R7 R8 
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region have shifted. These genetic studies suggest a role for Gbx2 in positioning the mid-
/hindbrain boundary (Wassarman et al., 1997; Millet et al., 1999; Simeone, 2000). 
 
Genes involved in neural crest migration 
Neural crest cells migrate away in streams from the neural tube to reach their destination in the 
facial primordia and branchial arches (see Fig. 1.2). The process of migration is regulated by a 
several genes, two of which will be discussed below. 
 
AP-2 
The transcription factor AP-2 is a retinoic acid responsive gene that is first expressed during 
neural crest determination, migration and in the facial primordia (Mitchell et al., 1991; Shen et 
al., 1997). In AP-2 mutant mice, the cranial neural tube fails to close., Moreover, abnormalities 
are found in the prechordal craniofacial skeleton (Schorle et al., 1996; Zhang et al., 1996). 
TUNEL analysis revealed that neuroepithelial cells and late migrating cranial neural crest cells 
are apoptotic (Schorle et al., 1996). Apparently AP-2 is involved with survival of premigratory 
and migratory cranial neural crest cells. 
 
PDGFDR 
Platelet derived growth factors (PDGFs) have been shown to regulate cell growth and survival, 
but also cell morphology and movement (for review see Cleasson-Welsh, 1994; Kazlauskas, 
1994). Two PDGF receptors exist, PDGFαR and PDGFβR (Seifert et al., 1989). Mice with 
mutations in PDGFαR, among which the Patch mouse (Ph), show a number of defects 
comprising cleft faces and spina bifida (Grüneberg and Truslove, 1960; Soriano, 1997). The 
cleft face phenotype has been associated with a defect in the migration and with apoptosis of 
migrating neural crest cells (Morrison-Graham et al., 1992; Soriano, 1997).  
 
Genes involved in patterning of the craniofacial primordia 
Members of many gene families are expressed in the developing craniofacial primordia, both in 
ectoderm and mesenchyme. Their outgrowth is dependent on proliferation of mesenchymal 
cells, which is tightly controlled by signals from the overlying epithelium and branchial pouch 
endoderm (Wedden, 1987; Richman and Tickle, 1992). 
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Fibroblast growth factor family (Fgf) 
At least 15 members of the Fgf family and the Fgf receptors-1, -2 and -3 are expressed in the 
developing craniofacial primordia. The Fgf ligands are expressed in the epithelium, while their 
receptors are expressed by the underlying mesenchyme (Drucker and Goldfarb, 1993; Wall and 
Hogan, 1995; Hartung et al., 1997; Bachler and Neubüser, 2001). Fgf2 and Fgf4 coated beads 
were shown to support outgrowth of the frontonasal process and mandibular arch mesenchyme 
in chick embryos (Richman et al., 1997). Fgf8 is expressed by the epithelium of the nasal pits 
and the first branchial arches. Hypomorphic Fgf8 mutant and conditional Fgf8 mutant mouse 
embryos have craniofacial and branchial arch abnormalities (Meyers et al., 1998; Trumpp et 
al., 1999). In humans several craniofacial syndromes are known to be due to mutations in FGF 
receptors, such as many forms of craniosynostosis (reviewed by Muenke and Schell, 1995; 
Wilkie et al., 1995; Wilkie et al., 1997). 
 
TGF-E superfamily 
TGF-β molecules, bone morphogenetic proteins (Bmps) and activins belong to the superfamily 
of transforming growth factor β (TGF-β)-signalling proteins. Many members and their 
receptors are expressed by the craniofacial primordia (Pelton et al., 1989, Pelton et al., 1991; 
Millan et al., 1991). Mutations in some TGF-β isoforms result in craniofacial abnormalities in 
upper and lower jaws and palatal shelves (Sanford et al., 1997; Kaartinen et al., 1995; Proetzel 
et al., 1995). Bmp2 and -4 null mutants die before onset of craniofacial development. 
Haploinsufficient Bmp4 mutants are viable and have abnormalities in frontal and nasal bones 
(Winnier et al., 1995; Zhang and Bradley, 1996; Dunn et al., 1997). Bmp7 mutants have 
abnormalities in cranial bones and in the skull base (Dudley et al., 1995; Luo et al., 1995). The 
short ear mutant was shown to carry mutations in the Bmp5 gene (Kingsley et al., 1992). 
 
Sonic hedgehog 
Shh is a signaling protein that is related to the Drosophila gene hedgehog (hh). Mouse Shh is 
expressed in the craniofacial primordia. It is expressed by the ectoderm and endoderm of the 
first branchial arch and in the ectoderm of the nasal processes. Shh mutants have severe 
craniofacial defects. Most defects are secondary to the defective splitting of the eye field, but 
some are directly caused by mutations in Shh. In Shh mutants the first branchial arch 
degenerates after E9.5, resulting in malformation or absence of most first branchial arch 
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derivatives at birth (Chiang et al., 1996). In chick, overexpression and inhibition of Shh 
signalling also results in severe craniofacial abnormalities (Hu and Helms, 1999). Evidence 
suggests that Shh plays a role in regulation of cranial neural crest cell survival (Ahlgren et al., 
1999). In humans, mutations in SHH are implicated in the etiology of holoprosencephaly 
(Belloni et al., 1996; Roessler et al., 1996). 
 
Retinoic acid receptor-D and  -  
Several types of retinoic acid receptors (RARs) have been identified. RAR-α, -β and - DQGWKH
retinoid X receptors, RXR-α, -β DQG  RAR-α and RAR-  are strongly expressed by the 
frontonasal process and branchial arches during and following neural crest migration (Ruberte 
et al., 1990). In RAR-α/RAR-  double mutant mouse skulls, all the structures derived from the 
frontonasal process were partially or completely absent (Lohnes et al., 1994; Mendelsohn et al., 
1994). The frontal, nasal, premaxillary, ethmoid and presphenoid bones were largely missing. 
In contrast, the derivatives of the mandibular process of the first arch were present and only 
little affected. These abnormalities probably result from increased cell death in the frontonasal 
mesenchyme at E10.5. Therefore retinoic acid may be required for survival of post-migratory 
neural crest cells within the frontonasal process (Lohnes et al., 1994).  
 
Gli genes 
Members of the Gli family are zinc finger containing proteins that show significant sequence 
similarity to the product of the Drosophila segment polarity gene cubitus interuptus (ci) 
(Ruppert et al., 1988; Orenic et al., 1990; Hui et al., 1994).  They are mediators of Shh 
signaling (Marigo et al., 1996; Lee et al., 1997). In both human and mouse, three closely 
related Gli genes exist, Gli1-3. During craniofacial development the Gli genes are expressed in 
the neural crest derived mesenchyme of the frontonasal process and branchial arches. Gli2 and 
Gli3 are also expressed in the migrating neural crest (Walterhouse et al., 1993; Hui et al., 
1994). Mutation of Gli2 results in truncation of the distal part of the maxilla and mandible. 
Moreover, loss of the presphenoid, maxillary bone and palatine shelves causes clefting in the 
skull of these mice. In contrast, mutations in Gli3 result in an enlargement of the maxillary 
region. Furthermore, the nasal processes are smaller and some clefting occurs. In Gli2/Gli3 
double mutants the abnormalities in the craniofacial region are enhanced (Mo et al., 1997). 
Mutation in Gli3 results in, amongst others, craniofacial abnormalities in the human syndrome 
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Greig’s cephalopolysyndactyly  (GCPS) and the extra toes (Xt) mouse (Johnson, 1967; Gollop 
and Fontes, 1985; Vortkamp et al., 1991, 1992; Schimmang et al., 1992; Hui and Joyner, 
1993).  
 
Msx genes 
The homeobox containing Msx genes are expressed in migratory and cranial neural crest 
derived mesenchyme. They have important functions in epithelio-mesenchymal interactions 
(Hill et al., 1991; Robert et al., 1989; Mackenzie et al., 1991a,b; Suzuki et al., 1991; Mina et 
al., 1995). In Msx1 mutant mice all facial structures fail to develop normally and they lack 
teeth (Satokata and Maas, 1994). Human syndromes exist that are associated with mutations in 
Msx1 and Msx2. MSX1 haploinsufficiency results in loss of premolar and molar teeth, but the 
facial skeleton develops normally (Vastardis et al., 1996). A mutation in one copy of human 
MSX2, causes craniosynostosis (Liu et al., 1996; Ma et al., 1996). 
 
Dlx genes 
Dlx genes are homeobox genes that are related to the Drosophila gene Distaless (Dll). In 
mouse 6 Dll-related genes exist. They are expressed in migrating cranial neural crest and in the 
cranial neural crest derived mesenchyme or ectoderm overlying the nasal pits (Qiu et al, 1995; 
Qiu et al., 1997; Acampora et al., 1999; Depew et al, 1999; Thomas et al., 2000). Dlx1, -2 and -
5 mutant mice have severe craniofacial abnormalities. Dlx2 mutants have abnormalities in 
proximal first and second arch derived structures, whereas Dlx1 mutants only have 
abnormalities in first arch derivatives (Qiu et al., 1995; Qiu et al., 1997). Dlx1/Dlx2 double 
mutants have similar abnormalities in both first and second arch derivatives as found in the 
single mutants. In addition, they lack the upper molars. Dlx5 mutants have abnormalities in 
ears, noses, lower jaw and calvaria (Depew et al., 1999; Acampora et al., 1999).  
 
aristaless-related genes 
aristaless (al) is a Drosophila gene that is expressed in central regions of the leg, eye and wing 
imaginal discs that grow out and become the most distal tips of the appendages (Schneitz et al., 
1993). It controls growth and differentiation of the tip of the leg (Campbell and Tomlinson, 
1998). In vertebrates, a large group of genes related to aristaless exists. They can be 
categorized in three classes of which class I genes are predominantly expressed in 
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mesenchymal structures of limb and craniofacial regions as described in Chapter 2. Among 
them are Alx4, the gene that is defective in the Strong’s Luxoid mutant, Prx1, Cart1, Prx2, 
Prx3 and Alx3 (Meijlink et al, 1999). 
 
Alx3, Alx4 and Cart1 are expressed by the frontonasal process and nasal processes, distally in 
the branchial arches and anteriorly in the limbs as described in Chapter 2. Alx4 and Cart1 
single and double mutant mice were generated in other labs. In Chapter 3 the generation of the 
Alx3 single and Alx3/Alx4 double mutants is described. Alx3 mutant mice do not have an 
obvious phenotype. In contrast, Alx4 mutants have preaxial polydactyly and mild craniofacial 
abnormalities. The human syndrome symmetric parietal foramina (PFM) is also caused by 
mutations in the ALX4 gene (Mavrogiannis et al., 2001; Wuyts et al., 2000). Cart1 mutant 
mice lack all skull vaults and have abnormalities in their skull base and facial skeleton (Zhao et 
al., 1995; Qu et al., 1997; Chapter 4 of this thesis). Alx4/Cart1 and Alx3/Alx4 double mutants 
have cleft nose regions and limb abnormalities (Qu et al., 1999; Beverdam et al., in press). 
These data, together with the results presented in Chapter 4 suggest that these three genes have 
overlapping functions in patterning the nasal processes and distal regions of the mandibular 
arch.  
 
Prx1 and Prx2 are also expressed in overlapping patterns by the frontonasal process, nasal 
processes and in the branchial arches as described in Chapter 2. Prx1 mutant mice were 
generated in E.N. Olson’s lab and Prx2 single and Prx1/Prx2 double mutant mice were 
generated both in our lab and by Lu and colleagues (ten Berge et al., 1998; Lu et al., 1999). 
Prx2 mutant mice do not have abnormalities. In contrast, Prx1 mutants display complex 
craniofacial phenotype including malformation of bones of the facial skeleton, the skull base, 
the otic capsule and second branchial arch derived structures (Martin et al., 1995). In 
Prx1/Prx2 double mutants, the Prx1 phenotype is enhanced suggesting overlapping roles for 
both genes in patterning of the mandibular and hyoid arch structures (ten Berge et al., 1998; Lu 
et al., 1999). 
 
Prx3 is expressed in foetal and adult brain, initially in broad areas that develop in the dorsal 
thalamus, pretectum and tectum. In the adult, the gene is most prominently expressed in nuclei 
that are part of the subcortical visual system (Van Schaick et al., 1997). In addition, it is 
Chapter 1 
 
 22
expressed by the craniofacial primordia and proximally in the limb buds (Chapter 2 of this 
thesis). Human Prx3 is a candidate gene for the Cornelia de Lange syndrome (De Lange, 1933; 
Blaschke et al., 1998; Semina et al., 1998). This syndrome is characterized by a combination of 
mental retardation, craniofacial features, eye defects and limb defects.  
SHOX is highly related to Prx3. The gene gives rise to at least two splice variants, SHOXA and 
SHOXB. Both are expressed in skeletal muscle and bone marrow fibroblasts. SHOXA is also 
expressed in placenta, heart and pancreas and SHOXB in the foetal kidney (Rao et al., 1997). 
SHOX is a pseudoautosomal gene that has been linked to idiopathic short stature and Turner 
syndrome (Rao et al., 1997; Shanske et al., 1999; Clement-Jones et al., 2000; Blaschke and 
Rappold, 2000, 2001). In addition, Prx3 is deleted in the similar Leri-Weill dysochondrosteosis 
syndrome (Belin et al., 1998; Shears et al., 1998; Blaschke and Rappold, 2000, 2001; Huber et 
al., 2001). 
 
Craniofacial birth defects 
Many babies are born each year with birth defects. The parents of one out of every 28 babies 
receive the frightening news that their baby has a birth defect. A birth defect is an abnormality 
of structure, function or body metabolism (inborn error of body chemistry) present at birth that 
results in physical or mental disability, or is fatal. A number of well known craniofacial 
disorders will be discussed below. 
 
Orofacial clefting 
Orofacial clefting is among the most frequently occurring cranial defect. Cleft lip with or 
without cleft palate occurs in 1 out of 350 births and cleft palate alone occurs less frequently. 
Cleft lip may be unilateral or bilateral. Unilateral cleft lip results from failure of one maxillary 
prominence to merge with the nasal processes, while bilateral cleft lips are due to the failure of 
both maxillary processes to fuse (see Fig. 1.7). Cleft palate, with or without cleft lip, is caused 
by a failure of the palatal shelves to meet and fuse with each other, with the nasal septum, 
and/or with the posterior margin of the primary palate (see Fig. 1.7). The causes of orofacial 
clefting are not fully understood. Studies suggest that a number of genes, as well as 
environmental factors, such as drugs (including antiseizure drugs), infections, maternal 
illnesses, maternal alcohol use and, possibly, deficiency of B vitamin folic acid may be 
involved (Thorogood, 1997). 
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Neural tube defects 
Neural tube defects (NTDs) occur in 1 of 1000 life births (Edmonds and James, 1990). Spina 
bifida, meningocele and meningomyelocele are caused by incomplete closure of the neural 
tube at spinal cord levels, whereas anencephaly and encephalocele are caused by neural tube 
closure defects at the more anterior brain levels (Campbell et al., 1986; Copp et al., 1990). The 
causes of the neural tube closure defects are in most cases unknown, but results from many 
studies show that there is a link between neural tube closure defects and decreased folate 
levels. Therefore treatment of pregnant mothers with folic acid at about 29 days of pregnancy 
strongly reduces the risk on neural tube closure defects (Smithells et al., 1989). Cart1 mutant 
mice have acrania and meroanencephaly at birth, but prenatal treatment with folic acid strongly 
reduces the incidence of neural tube closure defects (Zhao et al., 1996).  
 
Craniosynostosis 
Craniosynostosis is a birth defect that occurs in 1 out of 1600 and often occurs as a part of 
other malformation syndromes of which the best known are Apert, Pfeiffer, Saethre Chotzen 
and Crouzon syndromes. It is characterized by premature closing of one or more cranial sutures 
and it leads to malformation of the cranial cavity and other craniofacial features (Thorogood, 
1997). Dominant missense mutations in the gene encoding fibroblast growth factor receptors 
(FGFRs) 1-3 cause the development of many craniosynostosis syndromes (Muenke and Schell, 
1995; Wilkie et al., 1995; Naski and Ornitz, 1998). Recently a mouse mutant was generated 
A B
Fig. 1.7: Cleft lip and cleft palate. Frontal views on developing embryos. Black lines in A indicate 
positions where failure of fusion results in uni- or bilateral cleft lip. Black line in B indicates position 
where failure of fusion results in cleft palate. 
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with gain-of-function mutations in the Fgfr2 gene. This mouse has a phenotype with strong 
parallels to some Apert’s and Pfeiffer’s syndrome patients (Hajihosseini et al., 2001). 
 
Holoprosencephaly 
Holoprosencephaly (HPE) is a disorder with an incidence of 1 of 16.000 life births and 1 of 
250 induced abortions that results from a failure of the embryonic forebrain to separate into 
cerebral and lateral hemispheres, coupled with an abnormal development of the frontonasal 
process (Cohen, 1989a, 1989b, 1992). A progressive range of craniofacial malformations can 
be recognized. A mild phenotype involves absence of the intermaxillary process resulting in 
midfacial clefting. Further deficiency, coupled with a narrower midbrain and a suspected 
failure of midline definition of the bilateral olfactory placodes produces faces with reduced  
nasal structures, sometimes manifest as a small nose with a single nostril (cebocephaly). Even 
further reduction results in complete absence of nose and olfactory structures, with eyes 
developing much closer to the midline (hypotelorism). In most severe cases the defects results 
in a single eye present in the midline (cyclopia; Thorogood, 1997). Mutations in SHH were 
shown to cause HPE, making it an important candidate gene for the etiology of the syndrome 
(Belloni et al., 1996; Roessler et al., 1996). 
 
Treacher-Collins syndrome 
Treacher-Collins (TCS) is a rare autosomal dominant disorder that occurs in 1 of 50.000 live 
births (Gorlin et al., 1990). It affects the entire face: the lower jaw is underdeveloped 
(microagnathia), the palatine is cleft and the external ears are malformed, which often goes 
together with conductive deafness due to absent or dysmorphic ossicles (Thorogood, 1997). 
Mutations in the TCOF1 gene, mostly leading to premature stop codons, cause development of 
TCS (Dixon et al., 1997; Wise et al., 1997). Tcof1 haploinsufficiency in mice causes massive 
increase in the levels of apoptosis in the prefusion neural folds, which likely underlies the 
development of the craniofacial malformations (Dixon et al., 2000). 
 
DiGeorge syndrome 
DiGeorge syndrome (DGS) occurs with an estimated frequency of 1 in 4000 live births 
(Emanuel et al., 1999). Patients have the craniofacial defects as described for Treacher-Collins 
syndrome, but additionally both the thymus and parathyroids are either absent or reduced and 
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there are cardiovascular anomalies including persistent truncus arteriosus and dysmorphic 
aortic vessels. The parathyroid and thymic anomalies are likely consequences of phenotypes in 
third and fourth branchial pouches associated with defects in neural crest development and arch 
morphogenesis. The cardiovascular problems are thought to result from disruption of the 
cardiac neural crest, which emerges from the posterior hindbrain (Thorogood, 1997). DGS is 
usually associated with deletions of chromosome 22q11 (Scambler, 2000). Recent studies 
implicate the transcription factor TBX1 as a key candidate gene for the malformations seen in 
DGS (Jerome and Papaioannou, 2001; Lindsay et al., 2001). However, other genes within a 
closely linked region of 22q11, like CRKL, might affect the same developmental pathway 
(Guris et al., 2001). 
 
Aim of the Ph. D. project and this thesis 
At the start of this project our group had just begun to recognize that the aristaless-related 
genes have similar functions during embryonic development. We had cloned mouse Prx1 and 
Prx2, studied their expression patterns during development and suggested the current 
nomenclature (Leussink et al., 1995). The phenotype of the Prx1 mutant mouse had also been 
published (Martin et al., 1995). Derk ten Berge had generated the Prx2 mutant mouse and 
analysed the mouse Alx3 gene during his Ph. D. project (ten Berge et al., 1998a,b). In the Alx3 
expression paper we report the existence of a group of aristaless-related genes. The same year 
the phenotype of the Cart1 mutant mice was published. The description of the Alx4 mutant 
mouse phenotype followed soon after (Zhao et al., 1996; Qu et al., 1997). 
The aim of my project was to generate Alx3 mutant mice and to study its function and the 
functions of the highly related Alx4 and Cart1 genes during craniofacial development. In 
Chapter 2 the expression patterns of Alx3, Alx4, Cart1 and Prx1-3 in the craniofacial primordia 
and the outgrowing limbs are described. I suggest that a further categorization of group I 
aristaless-related genes in three subgroups could be made based upon protein structure, 
expression patterns and functional data. In Chapter 3, the generation of the Alx3 mutant mouse, 
the analysis of the Alx3/Alx4 double mutant embryos, the etiology of the phenotype and a 
probable cellular mechanism leading to the phenotype are described. Chapter 4 describes the 
skeletal phenotype of Alx3/Cart1 double and Alx3/Alx4/Cart1 triple mutant mice. 
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Abstract 
Homeobox genes can be grouped in many different classes, including the Hox genes and 
Paired-type homeobox genes (Galliot et al., 1999). A subgroup of the latter group is related to 
the Drosophila gene aristaless, which we therefore call aristaless-related genes. By definition, 
their gene products have an additional conserved domain, known as aristaless domain or OAR-
domain. On the basis of further similarities these genes are categorized in three groups, I-III 
(Meijlink et al., 1999). Group-I aristaless-related genes are linked to functions in the 
development of the craniofacial and appendicular skeleton and are characterized by 
predominantly mesenchymal expression in stages from late gastrulation through at least mid-
gestation (Zhao et al., 1994; Leussink et al., 1995; Qu et al., 1997; ten Berge et al., 1998a). 
Mutant studies reveal that Alx3, Alx4 and Cart1 have overlapping functions in patterning 
frontonasal regions and Alx4 functions to establish AP polarity in the limbs (Forsthoefel, 1963; 
Zhao et al., 1996; Qu et al., 1997; Takahashi et al., 1998; Qu et al., 1999; Beverdam et al., in 
press). Prx1 and -2 have overlapping functions in patterning the mandibular and hyoid arch 
and the limbs (ten Berge et al., 1998b; Lu et al., 1999a,b). The function of Prx3 has not yet 
been resolved. In view of the highly redundant character of the functions of these genes in 
patterning craniofacial and limb structures, we found it important to compare their expression 
patterns at critical stages of craniofacial and limb development directly. Group-I aristaless-
related genes are expressed in overlapping domains in the craniofacial and limb primordia and 
the comparative analysis suggests, in agreement with structural and functional data, a further 
classification in three subgroups: firstly Alx3, Alx4 and Cart1, secondly Prx1 and Prx2 and 
thirdly Prx3. 
 
Results and discussion 
Expression in craniofacial regions  
At E9.5 Alx3, Alx4 and Cart1 are highly expressed in the frontonasal process mesenchyme 
underlying the nasal placodes, but Cart1 is expressed in more ventral regions (see arrows Fig. 
2. 1A, E, I and Fig. 2.2A, B and C). Later they are highly expressed in the lateral and medial 
nasal process mesenchyme (see Fig. 2.1B to D, F to H and J to L and Fig. 2.2K, L and M). At 
E11.0, however, Cart1 expression is excluded from a dorsal region in the nasal processes that 
connects medial and lateral nasal processes (see region within circle in Fig. 2.1L). The nasal 
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processes will give rise to the inner and outer nose structures. In Alx3/Alx4 and Alx4/Cart1 
double mutants the nose regions are split up to the level of the anterior skull base (Qu et al., 
1999; Beverdam et al., in press). Therefore, this expression pattern correlates well with a role 
for Alx3, Alx4 and Cart1 in governing correct outgrowth of the nasal processes. At E10.5 Alx4 
and Cart1 are expressed in the distal tips of the maxillary process, in the region where they will 
fuse with the lateral nasal process (see arrows in Fig. 2.1F,J). Alx3 expression was not detected 
in the maxillary processes. In the mandibular component of the first arch expression of all three 
genes is observed in the extreme distal tip from E9.5 to E11.0 (see Fig. 2.1B, C, F, G, J, K and 
Fig. 2.2K, L, M). Alx4 expression, however, spreads to more proximal regions in caudal 
mandibular arch mesenchyme and Cart1 is expressed in a more oral domain encompassing a 
region where the lower incisors will develop (see Fig. 2.1G, K). Alx4/Cart1 and Alx3/Alx4 
double mutants have distally truncated lower jaws, which correlates well with the expression 
patterns of the genes (Qu et al., 1999; Beverdam et al., in press). At most, low expression of all 
three genes is detected in caudal regions of the second branchial arches from E10.5 onwards 
(not shown) and in neither of the double mutants any defects were reported in second arch 
derivatives.  
Prx1 and Prx2 are expressed in largely overlapping domains that differ distinctively from the 
expression domains of Alx3, Alx4 and Cart1. They are expressed in the frontonasal process and 
nasal process mesenchyme but at a lower level, which correlates with an absence of 
abnormalities in both single and double mutants in the nose region (see arrows in Fig. 2.1N, R). 
Prx1 is expressed in a continuous domain, but Prx2 expression is interrupted in the extreme 
dorsal mesenchyme (see Fig. 2.1S and T: region within the circles). High levels of expression 
were observed in the mesenchyme of the mandibular and hyoid arches, but expression was 
excluded from the most proximal parts of the arches in E9.5 to E11.0 mouse embryos (see Fig. 
2.1M to T). In Prx1 and -2 mutants defects are observed in regions derived from these 
structures (ten Berge et al., 1998b; Lu et al., 1999a). The palatal shelves and the squamosal are 
reduced, the lower jaw is severely truncated and its proximal structures are malformed. 
Moreover, second arch derived structures are also affected in Prx mutants. In addition, 
expression of Prx1 and Prx2 was detected in the otocyst (see arrowheads Fig. 2.1N, R) in 
accordance with mutation of Prx1 and Prx2 leading to inner ear defects.  
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Fig. 2.1: Expression of Alx3, Alx4, Cart1, Prx1-3 in whole mount E9.5 to E11.0 mouse embryos. 
First column shows semilateral views on E9.5 embryos, second column shows lateral views on E10.5 
embryos, Third column shows frontal views on E10.5 embryos and the fourth column shows frontal 
views on E11.0 embryos. Subsequent rows show expression patterns of Alx3, Alx4, Cart1, Prx1, Prx2
and Prx3, respectively. Diagrams illustrate crucial structures during craniofacial development in E9.5 
and E10.5 mouse embryos. Caudal ends of E10.5 and E11.0 embryos were removed to allow free 
view on craniofacial regions. Arrows in A, E and I point towards expression of Alx3, Alx4 and Cart1, 
respectively, in mesenchyme underlying nasal placodes. Arrows in F and J show expression of Alx4
and Cart1, respectively, in the maxillary process. Arrows in N and R point towards expression of 
Prx1 and Prx2, respectively, in the nasal processes. Arrowhead in N and R point towards expression 
of Prx1 and Prx2, respectively, in otocyst. Circles in L and S and T show region of nasal process 
mesenchyme from which expression of Cart1 and Prx2, respectively, is excluded. Staining in dorsal 
regions of the hindbrain as observed in D should be considered as an artefact. Note expression of 
Prx3 in mesencephalon in panel V and trigeminal and facio-acoustic complex in panel X. 
Abbreviations: FNP: frontonasal process; He: heart; LNP: lateral nasal process; Mn: mandibular 
arch; MNP: medial nasal process; Mx: maxillary process; O: otocyst; St: stomodeum; 2nd: 2nd
branchial arch. 
 
Chapter 2 
 32 
 
 Expression of Prx3 was very low in the mesenchyme of the frontonasal processes, but no 
expression was observed in the mandibular or second branchial arches (see Fig. 2.1U). At 
E10.5 and E11.0, on the other hand, relatively high levels of expression were detected 
exclusively in the medial nasal processes, proximally in the maxillary process, in the 
mandibular arch and in regions of the midbrain and cranial ganglia (see Fig. 2.1V, W and X).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2.2: Expression of Alx3, Alx4 and Cart1 in nearby serial transversal sections of E9.5 and E10.5 
mouse embryos. The first three columns show expression of Alx3, Alx4 and Cart1, respectively. The 
fourth column shows sections with locations of important structures. In the fifth column the red line 
shows the approximate plane of sectioning. The subsequent rows show nearby sections through E9.5 
frontonasal process (A-E), E9.5 forelimb bud (F-J), E10.5 facial processes (K-O) and E10.5 forelimb 
bud (P-T). Arrows in I and S show approximate antero-posterior polarity of section. Abbreviations: 
BA: mandibular arch; FL: forelimb; FNP: frontonasal process; HL: hindlimb; LNP: lateral nasal 
process; Mx, maxillary process. 
 
Orientation 
A B C D E 
FL 
F G H I J 
BA 
MNP 
K L M N O 
P Q R 
FL
HL 
FL 
A
P
S T 
Mx 
FNP 
LNP 
P 
A 
A 
P 
Alx3 Alx4 Cart1 Histology 
E9.5 
E9.5 
E10.5 
E10.5 
Expression patterns of group-I aristaless-related genes 
 33
Expression in limbs 
At E9.5 Alx3, Alx4 and Cart1 are expressed in the mesenchyme of the presumptive hindlimb 
buds and in the forelimb buds (see Fig. 2.3A, B, C and G, H and I and Y). In E9.5 embryos the 
hindlimbs have not yet grown out. In the presumptive hindlimb buds Alx3 and Alx4 expression 
appears to be restricted to more anterior regions, whereas Cart1 expression is visible 
throughout the limb bud (see Fig. 2.3A, B, C and Y).  In E9.5 embryos the forelimb buds have 
grown out (see Fig. 2.3G, H, I, Y). Alx3 and Alx4 are expressed anteriorly in the limb bud 
mesenchyme and expression domains extend to relatively distal regions (see Fig. 2.3G, H, Y 
and Fig. 2.2F, G). Expression of Alx3 was also detected proximally in posterior forelimb 
mesenchyme and in the flank. Interestingly, in contrast to previously published results, we do 
detect Cart1 expression in the limb bud (Zhao et al., 1994). Expression was found proximally 
in both anterior and posterior limb bud mesenchyme and it extends into the flank region (see 
arrows in Fig. 2.3I and Fig. 2.3Y). In E10.5 hindlimb buds expression of Alx4 is restricted to 
proximo-anterior domains and expression of Alx3 and Cart1 is found in anterior and posterior 
mesenchyme proximally in the limb bud (see Fig. 2.3S, T, U and Y). In E10.5 forelimb buds, 
Alx3 is expressed in proximal regions anteriorly in the forelimb and extends to the distal tip of 
the anterior forelimb bud, where it is expressed at a very low level (see Fig. 2.3S and Y and 
Fig. 2.2P). Alx4 expression remains restricted to a somewhat more proximal domain and Cart1 
is expressed most proximally in the forelimb bud (see Fig. 2.3S, T, U and Y and Fig. 2.2P, Q 
and R). Alx4 mutants have preaxial polydactyly and Alx4 was found to be involved in 
positioning the zone of polarizing activity to the posterior margin of the limb bud and 
preventing Shh expression in anterior limb bud mesenchyme (Qu et al., 1997; Takahashi et al., 
1998). The new insights in Cart1 expression in the early limb buds and the Alx3 expression 
pattern suggest that the genes have a similar function as Alx4 in limb patterning. Furthermore, 
these data explain the enhanced polydactyly in Alx4/Cart1 double mutants (Qu et al., 1999).  
Prx1 and Prx2 are also expressed at E9.5 both in fore- and hindlimb bud mesenchyme in a 
broad region along the distal limb margin (see Fig. 2.3D, E, J, K and Y). In the forelimb buds 
expression is graded at this stage, with highest levels in the more distal regions of the limb bud 
comprising the progress zone and lower levels in the more proximal limb bud. This graded 
expression is also observed one day later in both fore- and hindlimb buds (see Fig. 2.3P, Q, V, 
W and Y).  
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The expression patterns of Prx1 and Prx2 overlap but are considerably different compared to 
those of Alx3, Alx4 and Cart1 and the limb abnormalities in the Prx1 and -2 mutants have a 
different character than in the Alx4 mutant and Alx3/Alx4 and Alx3/Cart1 double mutants. The  
shortening of the zeugopod in Prx mutants most likely should be attributed to a defect later 
during development, during cartilage growth and differentiation, when Prx1 and Prx2 are 
expressed at E12.5 in the mesenchyme surrounding condensations and at E14.5 in the 
perichondrium (see Fig. 2.4). The autopod phenotype in the double mutants is relatively weak 
and variable and may be expressed either as pre- or postaxial polydactyly (ten Berge et al., 
1998b; Lu et al., 1999b). 
In E9.5 embryos Prx3 expression is detected only in the forelimb bud (see Fig. 2.3F, L and Y). 
Strikingly, the expression pattern is nearly complementary to the expression domains of Prx1 
and Prx2 at that stage, since it is excluded from the most distal limb margin, but it is highly 
expressed in more proximal areas. At E10.5 Prx3 is expressed both in fore- and in hindlimbs in 
a similar pattern as in the E9.5 forelimb buds, but now expression seems to be downregulated 
in a proximo-anterior region where Alx3, Alx4 and Cart1 are expressed (see Fig. 2.3R, X, Y).  
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expression in E9.5 
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shows expression in 
E10.5 hindlimb buds 
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E10.5 forelimb buds. 
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bud. Note expression of 
Prx3 in dorsal root 
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summary of expression 
data in limbs. 
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Conclusion 
Alx3, Alx4 and Cart1 are highly expressed in overlapping patterns in the frontonasal and nasal 
processes, distally in the mesenchyme of the first and second arches and in an anterior domain 
proximally in the outgrowing limbs. Prx1 and Prx2 are expressed at higher levels and in a 
broader region in the first and second branchial arches, but to lower levels in the frontonasal 
process and in the limbs they are highly expressed in a broad region along the limb margin. 
Expression of Prx3 overlaps that of the other five genes in craniofacial and limb regions, but 
has a significantly different character. These expression patterns suggest a classification of the 
aristaless-related group-I genes in three subgroups: One consisting of Alx3, Alx4 and Cart1, 
another of Prx1 and Prx2 and the last of Prx3. This is in line with similarities in gene structure 
and with results from functional studies as far as available. 
 
Experimental procedures 
Embryos and in situ hybridization: All procedures were carried out as described in Leussink 
et al., 1995 and ten Berge et al (1998). All animal experiments were conducted under the 
approval of the animal care committee of the K.N.A.W. (Royal Dutch Academy of Arts and 
Sciences).  
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Probes: Alx3, Cart1, Prx1 and Prx2: See Leussink et al., 1995 and ten Berge et al (1998). 
Alx4: A plasmid containing 0.6-kb Alx4 cDNA was cut with EcoRV and transcribed with T7 
polymerase. Prx3: A vector containing 220-bp rat Prx3A cDNA was cut with HindIII and 
transcribed with T3 RNA polymerase. 
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Summary 
A group of mouse aristaless-related genes has been implicated in functions in the development 
of the craniofacial skeleton. We have generated an Alx3 mutant allele in which the LacZ coding 
sequence is inserted in-frame in the Alx3 gene and the sequences encoding the conserved 
protein domains are deleted. Mice homozygous for this null allele are indistinguishable from 
wildtype mice. Compound mutants of Alx3 and Alx4, however, show severe craniofacial 
abnormalities that are absent in Alx4 single mutants. Alx3/Alx4 double mutant newborn mice 
have cleft nasal regions. Most facial bones and many other neural crest derived skull elements 
are malformed, truncated or even absent. The craniofacial defects in Alx3/Alx4 double mutant 
embryos become anatomically manifest around embryonic day 10.5, when the nasal processes 
appear to be abnormally positioned. Most likely this leads to a failure of the medial nasal 
processes to fuse in the facial midline and subsequently to the split face phenotype. We 
detected a significant increase in apoptosis localised in the outgrowing frontonasal process in 
embryonic day 10.0 double mutant embryos, which we propose to be the underlying cause of 
the subsequent malformations.  
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The vertebrate skull is classically subdivided in chondro-, neuro- and viscerocranium, which 
have different embryonic and evolutionary origins. Based on lineage studies in avian embryos, 
Couly et al. (1993) recognise a "chordal "and a "prechordal" (or "achordal") skull. While the 
chordal skull is derived from paraxial and cephalic mesoderm, the prechordal skeleton is 
entirely derived from the cephalic neural crest (reviewed in LeDouarin et al., 1993). This 
implies that the bones and connective tissues of the vertebrate face originate entirely from 
neural crest derived tissues. 
Facial development starts with the emergence of the five facial primordia: the frontonasal 
process and the paired mandibular and maxillary processes that are derived from the 
mandibular arch. These processes consist mainly of neural crest derived mesenchyme covered 
by epithelium. Outgrowth of the primordia occurs through controlled proliferation of 
mesenchymal cells, which depends in part on signalling from the overlying epithelium 
(Wedden, 1987; Richman and Tickle, 1992). As the facial prominences grow out, the nasal 
processes fuse in the midline with each other and laterally with the maxillary processes. 
Frequently occurring facial cleft disorders as known from human pathology and a number of 
mouse mutant models are in many cases thought to result from these fusion events going awry 
(reviewed in Thorogood, 1997).  
Morphogenesis of neural crest derived structures depends on the integrated action of several 
types of patterning genes (reviewed by Schilling, 1997). Genes responsible for early antero-
posterior patterning of the central nervous system, e.g., Hox and Otx genes, are to some extent 
responsible for the pre-programming of neural crest cells as they emigrate from the neural tube. 
Many other genes, including members of different homeobox gene families, exert their 
function in the mesenchymal cells that populate the facial processes. Other genes encode 
signalling factors including members of the Fgf- and Wnt-families and Sonic Hedgehog (Shh) 
are locally expressed in the epithelia that cover the processes or in adjacent endoderm. Cross-
talk between these two types of genes is likely to underlie in many cases the reciprocal 
epithelio-mesenchymal interactions known to be crucial in the development of the craniofacial 
skeleton (e.g., Ferguson et al., 2000). Aristaless-like homeobox genes form a distinct gene 
family whose members are characterised by a paired type homeobox and the presence of a 
small conserved carboxyterminal domain in the proteins encoded, known as aristaless or OAR 
domain (reviewed by Meijlink et al., 1999). A subset of these genes, including Prx1 and -2, 
Alx3, Alx4 and Cart1, are expressed during embryogenesis in similar patterns in neural crest 
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derived mesenchyme of developing craniofacial regions and in the mesenchyme of developing 
limbs (Leussink et al, 1995, Zhao et al., 1996; Qu et al., 1997; Ten Berge et al., 1998a). Mutant 
studies have established their partially redundant functions in these embryonic regions. For 
instance, studies of Prx1/Prx2 double mutant mice demonstrated the roles of these genes in 
craniofacial and appendage development. These mutants have severe reductions of mandibular 
arch derived structures, and in the zeugopod of the limbs (Ten Berge et al., 1998b; Lu et al., 
1999a and b). On the basis of sequence similarity and embryonic expression patterns, Alx3, 
Alx4 and Cart1 appear to represent a distinct subgroup (Ten Berge 1998a). Mice with 
mutations in Alx4, including the Strong’s Luxoid (lst) alleles, have strong preaxial polydactyly, 
mild craniofacial abnormalities in anterior components of the skull base and parietal and 
frontal bones as well as gastroschesis (Forsthoefel, 1963; Qu et al., 1997). Cart1 mutant mice 
have major cranial defects including acrania and meroanencephaly (Zhao et al., 1996).  
This study describes the generation and analysis of Alx3 null mutant mice. Alx3 single mutants 
appear to be normal, but Alx3/Alx4 double mutant mice have severe craniofacial malformations 
that are never seen in Alx4 single mutants.  
Double mutants are born with midfacial clefting and many neural crest derived skeletal 
elements are severely malformed. The anatomical abnormalities leading to the cleft nose 
phenotype are first detectable at E10.5 in medial craniofacial regions where Alx3 and Alx4 are 
strongly co-expressed. While in wildtype embryos the medial nasal processes fuse at E11.5, in 
Alx3/Alx4 double mutant embryos they develop in an abnormal lateral position, resulting in 
their failure to fuse. These defects correlate with abnormal and localised apoptosis at E10.0 in 
the nasal processes.  
 
Material and Methods 
Generation of the Alx3 knock out construct 
A fusion construct was made in pUC19 containing 3 kb LacZ coding sequence and a 3-kb 
loxP-pGK-TKNEOpA-loxP cassette that was transcribed in the reverse direction and flanked 
by loxP sites. A pUC19 vector containing pSDK-LacZ (gift of J. Rossant) was digested with 
KpnI, blunted and ligated to NotI adaptors. Subsequently, the linearised fragment was digested 
with SmaI. The loxP-pGK-TKNEOpA-loxP cassette was isolated by digestion with NotI and 
SmaI of pHR56 (gift of P. Kastner and F. Rijli) and was cloned into the linearised pUC19 
vector containing pSDK-LacZ. In pBR-GEM11 (gift of H. te Riele). 
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The SalI site in the polylinker was destroyed by partial SalI digestion, filling in of the 
overhangs and religation, generating pBR-*(0 SalI. Genomic fragments containing part of 
the Alx3 gene (see Fig. 3.1) were isolated by screening of a 129 SVJ mouse genomic library 
cloned in phage lambda FIX II vectors (Stratagene) with part of the Alx3 cDNA. A 1.9-kb 
genomic Alx3 PstI-NcoI fragment containing exon 2 was cloned in the pSDK-LacZ-loxP-pGK-
TKNEOpA-loxP fusion construct, resulting in an in frame fusion of Alx3 (exon 2) and LacZ 
sequences. The 7.4 kb NotI-SalI fragment containing the Alx3 (exon2)-LacZ-loxP-pGK-
TKNEOpA-loxP cassette was ligated into the NotI and XhoI site of pBR-*(0 6alI. 
Finally, a 5.5 kb genomic SalI fragment containing sequences 3’ of Alx3 exon 4 was inserted 
into the XhoI site of Alx3 (exon 2)-LacZ-loxP-pGK-TKNEO-pA-loxP-pBR-*(0 SalI, 
generating the complete targeting vector, pAlx3LacZ, containing 1.9 kb 5’- and 5.5 kb 3’- 
homologous sequence to the Alx3 locus (see Fig. 3.1). 
B: Targeting vector
A: Alx3 gene
C: Targeted Alx3 allele
5’ SstIStuI
probe9.5kb
3’ NcoIXhoI
probe9.5kb
Sa B SSaS S
3 4
P NRI RIS
2
SstIStuI
probe
NcoIXhoI
probe
11.5kb 7.5kb
RI SRINSP Sa S
LacZ pGK-TKNEOpA
 
2
5.5kb1.9kb
P N RISa S S
 
2
pGK-TKNEOpALacZ
SaS
S
S
Fig. 3.1. Targeted mutagenesis of Alx3. (A) Structure of the Alx3 locus: Exon 2, 3 and 4 are depicted 
by open rectangles. The homeobox and the aristaless-box (encoding the aristaless/OAR domain) are 
shaded. (B) Targeting vector: A 6 kb LacZ-loxP-pGK-TKNEOpA-loxP cassette was inserted in 
sequences of exon 2 upstream of the homeobox. 5’ 1.9 and 3’ 5.5 homologous sequences are 
indicated. Arrows in cassette indicate direction of transcription. (C) Targeted allele. The NcoI-XhoI 
probe corresponds to a region not present in the targeting construct, whereas the SstI-StuI probe 
detects the short homology arm. Relevant restriction sites and probes are indicated. Restriction 
fragments for Southern analysis are indicated with striped arrows above wildtype Alx3 allele and 
under targeted Alx3 allele. Coloured boxes: black, probes; red, loxP sites; blue, LacZ cassette; yellow, 
pGK-TKNEOpA cassette; green, homeobox; pink, aristaless-box. Restriction sites: N, NcoI; P, PstI; 
Sa, SalI; RI, EcoRI; S, StuI; B, BamHI. 
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Alx4 mutant 
Strong’s luxoid-J mice (official strain symbol Alx4lst-J) were obtained from the Jackson Lab 
(Bar Harbor). These mice carry an Alx4 allele containing a 16 bp deletion in the homeobox (Qu 
et al., 1998; Takahashi et al., 1998).  
 
ES cell manipulation 
A subclone from the E14 embryonic stem (ES) cell line was obtained from C. Brouwer, P. 
Krimpenfort and A.J.M. Berns (Neth. Cancer Inst, AmsterdDP  J SalI linearised 
pAlx3LacZ was electroporated into 4 x 107 ES cells. The ES cells were grown on irradiated 
mouse embryonic fibroblasts (MEFs) in 10 ml GMEM containing 1000 units/ml leukaemia 
inhibiting factor (LIF) in a 5% CO2-humidified incubator. From two days after electroporation, 
ES cells were selected in medium supplemented with 60% BRL-conditioned medium 
FRQWDLQLQJ *  JPO DQG /,)  XQLWVPO ZLWKRXW IHHGHU FHOOV WR LVRODWH 
individual neomycin resistant clones. Targeted ES cell clones were identified for correct 3’ 
integration by digestion of their genomic DNA with StuI. Southern analysis was performed 
using a unique NcoI-XhoI fragment of the 3’ Alx3 locus. The NcoI-XhoI probe binds to 
sequences of a 9.5 kb fragment of the wildtype locus and to a 7.5 kb fragment of the mutant 
Alx3 locus. Positive ES cell clones were subsequently checked for correct 5’ integration by 
digestion of their genomic DNA with EcoRI and Southern analysis using a unique SstI-StuI 
fragment of the 5’ Alx3 locus. The SstI-StuI probe binds to sequences of a 9.5 kb fragment of 
the wildtype locus and to an 11.5 kb fragment of the mutant Alx3 locus (see Fig. 3.1).  
 
Generation and breeding of mutant mice 
Chimaeric mice were obtained by injection of ES cells into C57BL/6 blastocysts. Chimaeric 
males were crossed with FVB/N females and heterozygous offspring was identified by coat 
colour and Southern analysis of tail DNA. Mice carrying the mutant Alx3 allele were crossed to 
homozygosity. The lstJ mutant was obtained from the Jackson lab. This mutant has been shown 
to have a 16-bp deletion in the homeobox of the Alx4 gene, resulting in loss of function (Qu et 
al., 1998). Alx3/Alx4 double mutant mice were bred on a mixed genetic background with 
contributions of OLA/129, FVB/N, C57BL/6J and B6C3H. All animal experiments were 
conducted under the approval of the animal care committee of the KNAW (Royal Dutch 
Academy of Arts and Sciences).  
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Genotyping 
Genotyping was done by PCR on tail tip or yolk sac DNA. Amplification of 326 bp of the Alx3 
wildtype allele was done by using: 5’-gaggctcaagaacaaggaagga-3’ (forward primer) and 5’-
ctaggagcaggtcagagcaggaag-3’ (reverse primer). Amplification of 821 bp of the LacZ gene by 
using 5’-tcgagctgggtaataagcgttggcaat-3’ (forward primer) and 5’-agaccaactggtaatggtagcgac-3’ 
(reverse primer) was done to identify the mutant Alx3 locus. Either 340 bp of the wildtype 
Alx4 locus or 324 bp of the mutant Alx4 locus was amplified using: 5’-caagccccctggaaaagacc-
3’ (forward primer) and 5’-ggtacattgagttgtgctgtcc-3’ (reverse primer, Qu et al., 1998). To 
distinguish these products they were restricted with PvuII and the products were separated on a 
3% agarose gel. The wildtype locus produces a 195-bp product and the mutant locus a product 
of 179 bp. 
 
Analysis of embryos and newborn mice  
Bone and cartilage staining was done according to a modified procedure of C. Fromental-
Ramain (IGBMC, Strasbourg). Foetuses and skinned and eviscerated new-born animals were 
fixed overnight in 96% ethanol, stained overnight for cartilage in 80% ethanol, 20% acetic acid 
+ 0.5 mg/ml Alcian blue (Sigma), rinsed 2 times in 96% ethanol for 3 hours and digested in 
1.5% KOH for 2 hours, followed by bone staining in 0.5% KOH + 0.15 mg/ml alizarin red S 
(Sigma) overnight, destained in several changes of 20% glycerol + 1% KOH and stored in 20% 
glycerol, 20% ethanol. Whole mount -galactosidase staining of E10.5 and E11.5 embryos was 
done as described (Hogan et al., 1994).  Whole mount in situ hybridisation was performed as 
described (Leussink et al., 1995). Shh, Ptc and Fgf8 probes were kind gifts of C. Tabin 
(Boston), R. Zeller (Utrecht) and G.R. Martin (San Francisco), respectively. Sections 
hybridised with radioactive probes were photographed by double exposure of dark-field and 
bright-field images; a red filter was used during the dark-field exposure. 
Cell proliferation was detected via analysis of BrdU incorporation into the DNA of dividing 
cells. Pregnant mice were treated with 1 ml 10mM BrdU in PBS per 100g body weight and 
embryos were isolated 75 minutes later. Embryos were fixed overnight in 4% 
paraformaldehyde, dehydrated, embedded in paraffin and 4-micrometer thick sections were 
prepared according to standard techniques. Sections of each embryo were distributed over three 
parallel series of object glasses. 
 Cleft faces and abnormal apoptosis in Alx mutants 
 45
BrdU was detected using a fluorescein-labeled monoclonal anti-BrdU antibody (Roche) 
according to the instructions of the manufacturer. The signal was enhanced using the Alexa 
Fluor 488 signal amplification kit for fluorescein-conjugated probes (Molecular Probes). 
Sections were counterstained with the fluorophore TO-PRO-3 (Molecular Probes), which 
stains nucleic acids. Each labelled section was scanned simultaneously for BrdU and TO-PRO-
3 signals in two different channels using a Leica TCS NT confocal laser-scanning microscope.  
Apoptosis was detected by TUNEL assay using the In Situ Cell Death Detection KIT (AP) 
5RFKH DFFRUGLQJ WR WKH LQVWUXFWLRQV RI WKHPDQXIDFWXUHUZLWK VRPH DGDSWDWLRQV 7KH  P
sections were rehydrated and in contrast to the manufacturer’s instructions sections were not 
treated with proteinase K. DNA was extended by terminal-deoxynucleotidyl transferase in the 
presence of fluorescein-labeled dUTP and incorporated fluorescein-labeled dUTP was 
subsequently detected with an anti-fluorescein antibody conjugated with alkaline phosphatase 
(AP). After substrate reaction with fast red apoptotic cells were detected using a light 
microscope. 
 
Results 
Generation of Alx3 mutants 
Alx3 mutant mice were generated through homologous recombination in ES cells. The 
targeting strategy is shown in Fig. 3.1. A LacZ sequence linked to a pGK-TKNEO cassette was 
inserted in frame in a site 28 bp upstream of the homeobox. Upon recombination the mutant 
allele was expected to express a fusion protein consisting of the first 132 amino acids of the 
Alx3 protein and the -galactosidase protein in a pattern identical to the Alx3 expression 
pattern. LoxP sites flanked the selection cassette allowing its subsequent deletion from the 
allele. The mutant Alx3 allele is expected to be functionally inactive as the protein encoded 
lacks both its conserved domains. Southern blotting using 3’ and 5’ probes confirmed 
successful targeting in at least 12 out of the 400 isolated ES cell clones (not shown). Three of 
these ES cell clones contributed to the germ line of chimaeric mice generated by blastocyst 
injection. Heterozygous mice for the Alx3 mutation appeared normal and were fertile. Two 
mouse lines were intercrossed and yielded wildtype, heterozygous and homozygous mutant 
offspring at the expected Mendelian frequencies. As the promoter region of the Alx3 locus 
including the large first intron remains intact in the knock-in allele, no major differences are 
expected in the LacZ expression as compared to Alx3 mRNA expression. Analysis of the β-
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galactosidase expression pattern in heterozygous embryos of E9.5 to E12.5 showed essentially 
no differences with the endogenous Alx3 expression pattern, confirming correct targeting of the 
gene (compare Fig. 3.2A with 3.2B for E10.5 embryos).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Alx3 null mice do not have obvious morphological abnormalities 
Alx3 heterozygous and null mutant mice were born at expected frequencies and did not display 
noticeable abnormalities. They were fertile and appeared to have a normal life span. Since Alx3 
is expressed predominantly in mesenchyme of developing limbs and craniofacial regions (Ten 
Berge et al., 1998a; Beverdam and Meijlink, 2001; Fig. 3.2) skeletons of null mutant newborn 
mice were thoroughly analysed, but no abnormalities were observed.  
 
Abnormalities in Alx3/Alx4 double mutant include severe craniofacial 
defects 
Alx3 and Alx4 encode highly related proteins (Qu et al., 1997; Ten Berge et al., 1998a); in 
addition, their expression patterns are highly similar, as we demonstrate in Fig. 3.2 C-J (see 
also Beverdam and Meijlink, 2001). In facial primordia at early embryonic stages (Fig. 3.2C- 
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Fig. 3.2: Essentially correct Alx3/LacZ 
expression in knock-in mice; comparative 
expression analysis of Alx3 and Alx4 in 
E10.5 embryos. (A) Detection of Alx3
mRNA (whole mount in situ hybridisation) 
in whole embryo. (B) LacZ expression in 
Alx3+/- mouse embryo. Expression of Alx3
and LacZ are qualitatively identical, 
confirming proper targeting of the Alx3
locus. Staining in brain vesicles in panel A 
is background staining. (C,D) Radioactive 
in situ hybridisation showing overlapping 
expression of Alx3 and Alx4 in frontonasal 
processes (FNP) at E9.5. (G,H) Expression 
of Alx3 and Alx4 in medial nasal process 
(MNP) and mandibular arch (BA) at E10.5. 
(E,I) schemes indicating approximate 
orientation of sections. (F,J) Whole mount 
in situ hybridisation of E10.5 embryos 
showing overlap of expression in cranium 
and anterior mesenchyme of limbs.  
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H) there is considerable overlap of the expression domains, while the Alx4 expression domain 
extends more laterally. In limb buds expression of both genes is almost identical (Fig. 3.2F,J).   
It is therefore very likely that Alx3 and Alx4 have overlapping functions, and for that reason we 
decided to generate Alx3/Alx4 double mutant embryos. We crossed Alx3 mutants with Strong’s 
luxoid Jackson (Alx4lst-J)  mice, that are known to carry a defective Alx4 allele (Qu et al., 1998; 
Takahashi et al., 1998). Alx4 mutants have preaxial polydactyly, abnormalities in the skull and 
frequently gastroschesis (Forsthoefel, 1963; Qu et al., 1997).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Alx4 single and Alx3/ Alx4lst-J double mutant mice had preaxial polydactyly of the fore- and 
hind limbs as described for Alx4 mutant mice (see Fig. 3.3; Forsthoefel, 1963; Qu et al., 1997). 
Penetrance and severity of the Alx4 phenotype are known to depend greatly on genetic 
background (Forsthoefel, 1968). In contrast with Alx4/Cart1 double mutant mice (Qu et al., 
1999), Alx3/ Alx4lst-J double mutant had no significant aggravation of the polydactyly. We 
noted that both Alx4 mutants and double mutants lacked the deltoid crests (arrows in Fig. 3.3A-
C). These processes are located anteriorly on the humeri of normal forelimbs, and their absence 
may therefore be interpreted as a proximal expression of a mirror-image-duplication phenotype 
in the limb. This phenotype has not previously been described for any Alx4 mutant, but has 
been found as an aspect of the extensive mirror image duplication that can be caused by Hoxb8 
overexpression (Charité et al., 1995). Alx3/ Alx4lst-J double mutant mice had a reduction of the 
medial (sternal) end of the clavicle, a phenotype absent from the Alx4lst-J mutant (see 
A
Control
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Alx3+/+;Alx4-/-
*
B
Alx3+/+;Alx4-/-
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Alx3-/-;Alx4-/-
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D
Fig. 3.3: Forelimb and pectoral girdle defects in Alx mutants. Alizarin red (bone) Alcian blue 
(cartilage) stained forelimbs and pectoral girdles. Genotypes: (A,D) Alx3+/-/Alx4+/+; (B,E) 
Alx3+/+/Alx4lst-J/lst-J; (C,F) Alx3-/-/Alx4lst-J/lst-J. Arrowheads point towards the clavicle and arrows point 
towards (normal position of) deltoid crest. Asterisk marks extra digit in B and C. (D-F), dissected 
clavicles; double arrows and L-M indicate Lateral-Medial orientation of the clavicles. 
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arrowheads in Fig. 3.3A-C and Fig. 3.3D-F). Therefore in the shoulder girdle, but not in the 
limb itself, nor in the pelvic girdle, a function of Alx3 was demonstrable.  
While in Alx3+/-/Alx4lst-J/+ mice no craniofacial abnormalities were detected and Alx3+/+/ Alx4lst-
J/ lst-J
 mutant mice have only relatively mild craniofacial abnormalities, Alx3-/-/Alx4lst-J/lst-J, Alx3-
/-/Alx4lst-J/+ and Alx3+/-/Alx4lst-J/lst-J mice had a broader and shorter cranium and displayed 
variable facial clefting comprising the entire nose region (see Fig. 3.4). Generally, they died 
within a few hours after birth with empty stomachs and air in their intestines, apparently as a 
consequence of craniofacial defects leading to inability to breath, or due to the ventral body 
wall defects as described for the Alx4 mutant mouse (Qu et al., 1997). Eyelid abnormalities, as 
described by Forsthoefel (1963) for Strong’s luxoid (Alx4) mutants, were enhanced in double 
mutants. In Alx3-/-/Alx4lst-J/lst-J newborn mice, the eyes were consistently wide open with 
complete penetrance (compare Fig. 3.4D with 3.4A-C). This aspect of the phenotype is 
apparently an indirect consequence of other cranial defects that make the eyes bulge out 
(Forsthoefel, 1963).  
 
 
 
 
 
 
Control Alx3+/+/Alx4-/- Alx3+/-/Alx4-/- Alx3-/-/Alx4-/-
A B C D
E F G H
Fig. 3.4. Cranial phenotype of newborn Alx3/Alx4lst-J double mutant mouse. Lateral (A-D) and frontal 
(E-H) views on crania of Alx3+/- (A,E), Alx4lst-J/lst-J (B,F), Alx3+/-/Alx4lst-J/lst-J (C,G) and Alx3-/-/Alx4lst-
J/lst-J
 (D,H) newborn mice. The anterior region is truncated, the nose is split and the eyes are open. 
Note abnormal appearance of skull vault due to reduced parietal frontal and nasal bones in D. The 
severity of the cleft nose phenotype is highly variable. 
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Most facial bones are malformed in Alx3/Alx4 double mutant mice 
We performed a detailed analysis of skulls of newborns with various double mutant genotypes 
using skeletal stainings (Figs 3.5, 3.6) and histological sections (Fig. 3.7 for E12.5 and E13.5; 
see also Fig. 3.9 for earlier stages). A gradual increase in the severity of the phenotype was 
found, being weakest in the Alx3+/+/Alx4lst-J/lst-J mutant mice and becoming progressively 
stronger in Alx3-/-/Alx4lst-J/+, Alx3+/-/Alx4lst-J/lst-J and Alx3-/-/Alx4lst-J/lst-J mutant mice as 
demonstrated in Fig. 3.5. Double mutants displaying a mild phenotype had only a partially split 
nasal tip, but in mutants with extreme phenotypes both lateral halves of the nose were 
anteriorly truncated and spaced wide apart. Most facial bones and many of the membranous 
bones of the vaults were affected in double mutants (compare in Fig. 3.6 panels A,E with C,G). 
In homozygous Alx4 mutant mice the parietal and frontal bones are reduced (See Fig 3.5; 
Forsthoefel, 1963) and recent studies reveal that in humans, ALX4 haploinsufficiency is 
associated with ossification defects in the parietal bones (Wuyts et al, 2000; Wu et al., 2000; 
Mavrogiannis et al., 2001). We observed in Alx3/Alx4lst-J double mutant newborn skulls an 
aggravation of the vault phenotype: besides a stronger reduction in the size of the frontal and 
parietal bones, the nasal bones were also affected, causing wide fontanels (compare in Fig. 3.6 
panels A,B with C,D). The nasal capsule was divided in two separate halves both closed by 
remnants of the nasal septum while a medial nasal septum was absent (see white arrows in Fig. 
3.5 and see Fig. 3.6C,G). The nasal labyrinths and the anterior part of the nasal capsule were 
severely malformed and strongly curved (Fig. 3.5, lower panels; Fig 3.7, compare A ,E with 
B,F for the situation at E12.5 and E13.5). Also the premaxilla and maxilla were strongly 
affected and positioned abnormally laterally, and the palatine was cleft (Fig 3.6, structure 
marked ’P’ in F,H). In the mandible the distal part of the dentaries was truncated, but the 
incisors were normally present (see Fig. 3.5). The proximal part of the mandible seemed 
unaffected. The more lateral skull bones consisting of the alisphenoid bones and squamosal 
bones were malshaped and reduced (see structures marked ’As’ and ’S’ in Fig. 3.6 F,H). The 
neural crest derived skull base, consisting of the basipresphenoid and the pterygoid processes 
was also severely malformed and appeared broader (see green arrowheads in Fig. 3.5 and 
asterisks in Fig. 3.6E,G). More posterior skull structures derived from cephalic and somitic 
mesoderm like the posterior elements of the sphenoid bone, the occipital bone and the otic 
capsule, tympanic ring, inner and middle ear structures were normal in double mutants (see  
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Alx3+/-/Alx4+/+
Alx3+/+/Alx4-/-
Alx3-/-/Alx4+/-
Alx3+/-/Alx4-/-
Alx3-/-/Alx4-/-
Dorsal view
+ vaults
Dorsal view
- vaults
Ventral view
- vaults
Dorsal view
mandible
Alx3-/-/Alx4+/+
Fig. 3.5. Craniofacial abnormalities in Alx3/Alx4lst-J  double mutant newborn mice. Alizarin red 
(bone)/Alcian blue (cartilage) stained skulls are shown. First column shows a dorsal view on the 
vaults of the skulls. Second column shows dorsal views on skulls from which vaults were dissected. 
Third column shows a ventral view on skulls from which mandibles were dissected. Fourth column 
shows the dissected mandibles. Genotypes are indicated to the left. Green arrows point towards the 
basipresphenoid, which constitutes the border of neural crest derived skeletal elements and cephalic 
and somitic mesoderm derived skeletal elements. White arrows point towards nasal septum. 
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Fig. 3.6. Craniofacial abnormalities in Alx3-/-/Alx4lst-J/lst-J double mutant newborn mice. Photos and 
corresponding diagrams of control and Alx3/Alx4lst-J double mutant skulls. Upper half shows dorsal 
view on vaults of control (A,B) and Alx3/Alx4lst-J double mutant (C,D) skulls. Lower half shows 
ventral views on skulls from which mandible was dissected of control (E,F) and Alx3/Alx4lst-J  double 
mutant (G,H) mice. All skeletal elements are represented by a colour in the diagrams as indicated in 
the legend. Asterisks in E and G indicate positions of pterygoid processes. Abbreviations: As, 
alisphenoid bone; Bo, basioccipital bone; Bs, basisphenoid bone; M, maxilla; Ns, nasal septum; P, 
palatine; Ps, basipresphenoid bone; S, squamosal bone; So, supraoccipital bone. 
 
Fig. 3.7. Histological analysis of cranial phenotype. Transversal sections of wildtype (A,C,E,G) and 
Alx3-/-/Alx4lst-J/lst-J (B,D,F,H) embryos. Stage (embryonic day) is indicated in left lower corner. 
Asterisks, nasal septum precartilage condensation; arrows, nasal cavity; arrowheads, Jacobson’s 
(vomeronasal) organ. Schemes below, with stages indicated, show approximate plane of section. 
Abbreviations, ps, palatal shelves, to, tongue. 
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Figs 3.5-3.7). This region of the skull appears somewhat broader which may be explained as a 
consequence of the anterior truncation of the skull that forces the more posterior skeletal 
elements outward, to allow the brain to expand (Forsthoefel 1963). Histological sections of 
E12.5 and E13.5 embryos demonstrate for these stages the normal morphology in posterior 
cranial structures, for instance the palatal processes and tongue in Fig 7A-D), while more 
anteriorly the nasal cavities are malformed (arrows in Fig 7A,B,E,F). Fig 7G,H shows the cleft 
’nasal septum’.  The skeletal elements derived from second and third arch mesenchyme, which 
form the hyoid skeleton were unaffected (not shown). 
 
The abnormalities in Alx3/Alx4 double mutants arise around E10.5 
To define when the craniofacial defects in Alx3/Alx4lst-J double mutants first become apparent, 
control embryos and Alx3-/-/Alx4lst-J/+, Alx3+/-/Alx4lst-J/lst-J and Alx3-/-/Alx4lst-J/lst-J embryos were 
analysed from gestational day 9.5 to 15.5 (see 3. 8). 
At E9.5, craniofacial regions of wildtype embryos are composed of the primitive facial 
primordia that are arranged around the stomodaeum. The facial primordia consist of the 
frontonasal process and the protrusions of the first branchial arch. At E10.0 the nasal placodes 
become slightly indented, causing the formation of the medial and lateral nasal processes. 
Analysis of E9.5 and E10.0 Alx3-/-/Alx4lst-J/lst-J whole mount and sectioned embryos revealed no 
abnormalities in the first branchial arch or frontonasal processes (not shown). At E10.5 in 
normal embryos the lateral and medial nasal processes enclose the nasal pits; the medial nasal 
processes will fuse in the midline around E11.5 forming the nasal septum. The primary palate 
is formed by fusion of the inferior borders of the medial nasal processes. From the medial walls 
of the maxillary processes palatal shelves grow out that fuse in the midline with the inferior 
border of the nasal septum, which grows down from the frontal process. Anteriorly, the shelves 
fuse with the primary palate resulting in the formation of the secondary palate.  
In E10.5 Alx3-/-/Alx4lst-J/lst-J embryos the nasal processes are spaced more laterally than in 
wildtype embryo’s (compare arrowheads in 3.8A and E). The abnormally wide spacing became 
more pronounced later during development and resulted in defective merging of the nasal 
processes in the midline (compare arrowheads in Fig. 3.8B-D with F-H). Moreover, fusion of 
the maxillary processes with the lateral nasal processes occurred more laterally than in 
wildtype littermates, causing an abnormal shape and position of skeletal elements of the upper 
jaw. Fig 3.7C,D,G,H (arrowheads) shows the presence of the nasal labyrinth, nasal septum 
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remnants and vomeronasal organs within the unfused nasal processes in sections of E12.5 and 
E13.5 embryos. Instead of one medial mesenchymal condensation forming the cartilaginous 
nasal septum, two lateral condensations were detected, leaving an open space in the midline, 
which was continuous with the oral cavity due to the cleft palate (Fig. 3.7E-H). In Fig. 3.8D,H 
LacZ expression in E11.5 control embryos is shown to illustrate Alx3 expression in the medial 
nasal processes, as well as that this domain becomes much wider in the double mutant. It thus 
appears that the defects observed in the Alx3/Alx4lst-J double mutant mice were directly or 
indirectly caused by the abnormal lateral position of the nasal processes in E10.5 embryos.  
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Fig. 3.8. Aetiology of the split nose phenotype. The nasal processes of Alx3/Alx4lst-J double mutant 
embryos fail to fuse around E11.5. Shown are frontal views on control (A-D; either Alx3+/- or 
wildtype) and stage-matched Alx3/Alx4lst-J double mutant embryos (E-H) of E10.5 to E11.5 as 
indicated above photos. Posterior regions of most of the embryos were cut off to allow free view on 
the nasal processes. In the embryos of E11.5 the Alx3 expression domain was visualised by X-gal 
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-galactosidase. Arrowheads point to medial edges of the medial nasal processes, 
demonstrating the improper outgrowth and fusion of the nasal processes in double mutant embryos. 
Note the increasing difference in distance between the processes of control and Alx3/Alx4lst-J double 
mutant embryos. 
 
Chapter 3 
 54 
 
Gene expression in Alx mutants 
As a next step to understand the basis of the Alx phenotype, we compared the expression in 
normal vs. double mutant embryos of a number of selected genes in whole mount or sectioned 
embryos of E9.5 to E11.5.  
Shh is expressed in a distinct region of the ectoderm covering the medial nasal processes from 
E9.5 onwards (see arrow in Fig. 3.9A). It is known to be upregulated in anterior limb bud 
mesenchyme of Alx4 mutants (Chan et al., 1995), and downregulated in mandibular epithelium 
of Prx1/Prx2 double mutants (Ten Berge et al., 2001). In double mutants at E10.5 but not at 
earlier stages, the expression domain in nasal epithelium is expanded to the same degree as the 
skull is wider (compare Fig. 3.9A with B,C). The expression pattern of the direct Shh target 
gene Ptc was changed accordingly (not shown). As the change of the expression pattern seems 
to follow the anatomical abnormalities, rather than vice versa, we do not believe that Shh and 
Ptc are downstream target genes of Alx3 and Alx4, but rather that the changes in expression 
domains are secondary to the morphological changes. Fgf8 is expressed in restricted regions in 
the oral ectoderm of the first branchial arch, in the ectoderm of the nasal pits and more distally 
in the medial nasal process ectoderm (see Fig. 3.9E). In Alx3/Alx4lst-J double mutant embryos 
of E9.5 to E11.5 we could not detect obvious changes in the Fgf8 expression pattern (see Fig. 
3.9E,F).  
Pax9, Prx3 and Bmp2 have distinct expression patterns in mesenchyme of developing 
craniofacial primordia. We compared their expression domains in control embryos of E10.5 
and E11.5 with those in Alx3/Alx4lst-J double mutant embryos. Fig. 3.9 G-L shows the results 
for Pax9, known to have an important role in patterning of mesoderm and endoderm of the 
pharynx, and which is expressed in nasal, mandibular and maxillary processes. At E 10.5 the 
expression patterns in control vs. wildtype embryos are indistinguishable, while at E11.5 the 
changes observed appear to be a consequence of the anatomical abnormalities that are clearly 
visible around this stage. For instance, Pax9 is expressed laterally from the precartilage 
condensation in the midline of the nasal septum around the vomeronasal organs (Fig. 3.9H) and 
around the nasal cavities (Fig. 3.9I). In the highly abnormal nasal septum remnants the domain 
is split apart but essential characteristics like its location with respect to the epithelium and 
surrounding the vomeronasal organs and nasal cavities appear to be retained (Fig. 3.9K,L). 
Similarly, Bmp2 (not shown) and Prx3 (Fig. 3.8M-R), a family member of the Alx genes also 
known as Shot or OG-12, which we selected because of the overlap of its expression domain 
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with those of Alx3 and Alx4 in the medial nasal process, were normally expressed at E10.5, and 
at E11.5 in a way more or less predictable from the phenotype. This marker gene expression 
study therefore is informative because it contributes to the histological analysis of the mutant 
embryos, but does not provide clues as to the molecular mechanisms underlying the phenotype. 
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Fig. 3.9. Study of phenotype 
by analysis of expression 
patterns of marker genes in 
serial sections. Probes used 
are specified to the right of 
the Figure. Panels A, E, G-I, 
M-O are control embryos 
(either Alx3 heterozygotes or 
wildtype) panels B, C, F, J-L, 
P-R are Alx3-/-Alx4lst-J/lst-J. 
Panels A-F show serial 
sections of two E10.5 
embryos and expression of 
ectodermal markers, where D 
is a scheme to indicate 
approximate plane of sections 
in the embryos used in this 
experiment. Panels G-R show 
nearby serial sections of two 
control and two double 
mutant embryos and 
expression of two 
mesenchymal markers. Panels 
G, J, M, N show E10.5 
embryos; H, I, K, L, N, O, Q, 
R show rather advanced 
E11.5 embryos. Orientation of 
sections of this series of 
embryos is depicted in lower 
row of panels. Arrows (in A-
C) indicate Shh expression in 
ectoderm of the medial nasal 
processes. Abbreviations: BA, 
branchial (mandibular) arch; 
FB, forebrain; FNP 
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heart; HB, hindbrain; Man, 
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palatal shelf (part of maxilla); 
To, tongue. 
 
Chapter 3 
 56 
 
Alx3 and Alx4 control cell survival in the frontonasal mesenchyme at 
E10.0 
To investigate the cellular basis of the facial phenotype of the Alx3/Alx4lst-J double mutant mice 
we performed BrdU incorporation assays to analyse proliferation patterns and TUNEL assays 
to detect apoptosis in embryos of around the developmental stages when the abnormalities first 
become obvious. 
We studied cell proliferation in control and double mutant embryos of E9.5, E10.0 and E10.5. 
In both control and double mutant embryos BrdU incorporation appeared highest in the 
mesenchymal cells flanking the deepening nasal placode and became lower towards more 
medial regions of the frontonasal process. We were not able to detect obvious differences in 
proliferation rates between double mutant and control embryos (not shown). 
We next studied apoptosis in transversal tissue sections of E9.5 and E10.0 control and double 
mutant embryos by performing TUNEL assays. In E9.5 embryos we did not observe any 
difference in cell death in control and double mutant embryos (not shown). In two double 
mutant embryos of E10.0, however, we observed two contralateral areas containing abnormally 
high numbers of apoptotic cells dorsolaterally in frontonasal mesenchyme adjacent to the 
placodes (Fig. 3.10 A-G). We counted 30 adjacent 4- P VHFWLRQV LQ ZKLFK WKH QXPEHU RI
apoptotic cells was significantly higher compared to corresponding regions in five control 
embryos (compare Fig. 3.10 B,E with A,D). The part of the frontonasal process where the 
apoptotic cells were observed falls within the region where Alx3 and Alx4 are both highly 
expressed (see Fig. 3.2C-H). This region contributes to the development of the nasal processes 
that will ultimately give rise to the nasal capsule, premaxilla and primary palate. In E10.5 
embryos we detected essentially the same patterns of apoptotic cells in mutants and wildtypes. 
In the region presumably corresponding to the area where we saw the enhanced apoptosis in 
E10.0 embryos, we saw the same very low levels of TUNEL-positive cells in wildtypes and 
mutants (Fig. 3.10H,I). In E11.5 embryos we did not see any TUNEL-positive cells in nasal 
mesenchyme (Fig. 3.10K,L). 
We conclude that the lack of Alx3 and Alx4 early during craniofacial patterning leads to loss of 
cell survival in a confined area during a small time window. We deem it possible that this 
seemingly minor effect suffices to subsequently lead to abnormal outgrowth of the medial 
nasal processes. We propose that this early developmental anomaly contributes significantly to 
the rather dramatic phenotype seen in newborns.  
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Fig. 3.10: Apoptosis in Alx3/Alx4lst-J double mutant embryos. In a restricted region of the frontonasal 
process of Alx3/Alx4lst-J double mutant embryos a significant number of mesenchymal cells undergo 
apoptosis compared to stage matched control embryos. Panels A,D, F, H, K represent control 
embryos (wildtype or Alx3+/- ); panels B,E,G,I,L represent embryos of double mutant embryos; 
panels C,J,M are schemes depicting plane of sections of embryos shown to their left. TUNEL assays 
were done to detect apoptosis. Positive cells appear red in this assay, as seen in brightfield images 
(panels A,B,F,G). Because of difficulty with visualising TUNEL staining simultaneously with 
histology, we show also darkfield images where positive cells appear as white to orange spots. The 
yellow squares in panels D and E mark the crucial area where we found differences in apoptosis in 
E10.0 embryos. These areas are shown enlarged, and in brightfield, in panel G. No or very few 
apoptotic cells were detected in the vicinity of the nasal processes of embryos of E10.5 and E11.5. 
The yellow arrows in panels H and I point to apoptopic areas in the maxillary component of the first 
branchial arch, confirming that the negative result in this experiment was not due to technical failure. 
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Discussion 
We report that mice that lack the aristaless-related homeobox gene Alx3 do not display 
anatomical abnormalities or diminished health. This suggested to us that loss of Alx3 is 
compensated by genes with overlapping functions, which was confirmed when we analysed the 
phenotype of mice double mutant for Alx3 and Alx4. These genes are structurally highly related 
and are expressed in similar expression patterns in developing embryos. Alx4 loss-of-function 
mutants, including Strong’s luxoid mutants and Alx4 targeted knockouts, have a complex 
phenotype including preaxial polydactyly, and mild abnormalities in the skull (Forsthoefel, 
1963; Qu et al., 1998 and 1999). Mice double mutant for Alx3 and Alx4lst-J null alleles had 
severe abnormalities in the skull that are not seen in Alx4 mutants, although other aspects of the 
Alx4 phenotype were at the most marginally aggravated. Alx3/Alx4lst-J double mutants have 
severe clefting of the nose region. We noted the earliest signs of anatomical abnormalities in 
the head region around gestational day 10.5, when the nasal processes grew out abnormally 
laterally. The wide lateral spacing of the processes resulted in failure to fuse, and ultimately in 
the cleft nose phenotype in newborn mice. Analyses of cellular parameters in early double 
mutant embryos demonstrated increased cell death in restricted regions of the presumptive 
nasal processes, which is most likely causally linked to the subsequent abnormal 
morphogenesis of the nasal processes.  
 
Overlapping functions of Alx3, Alx4 and Cart1  
Alx3 and Alx4 are expressed in overlapping domains in neural crest derived mesenchyme of 
medial regions of the developing facial primordia (Qu et al., 1997; Ten Berge et al., 1998). 
These regions grow out to form the cartilages, bones and connective tissues of the face and the 
most anterior part of the skull base.  
Cart1 is a third protein that is highly related to Alx3 and Alx4. These three proteins share very 
similar homeodomains, a common C-terminal domain called aristaless- or OAR domain, and 
additional sequence similarity between these two domains that sets them apart at the structural 
level from other aristaless-related proteins. Cart1 expression in craniofacial regions is spatially 
and temporally similar to that of Alx3 and Alx4, but Cart1 expression is detectable earlier in the 
head mesenchyme. Cart1 mutant mice have a strong cranial phenotype caused by cranial 
neural tube closure defects that lead to acrania and meroanencephaly at the time of birth (Zhao 
et al., 1996). In addition, these mice have other, relatively mild craniofacial defects. It is 
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striking that, like Alx3/Alx4lst-J mutants, Alx4/Cart1 double mutant mice have severe midfacial 
clefting and distally truncated mandibles (Qu et al., 1999). In contrast with our conclusions on 
the early anatomical basis of the cleft-nose phenotype of the Alx3/Alx4lst-J mutants, the 
phenotype of the Alx4/Cart1 double mutant mice has been explained as a failure of the “nasal 
cartilages to fuse” (Qu et al., 1999). In view of the similar molecular basis of the defect in both 
cases, we consider it quite likely, however, that in both double mutants the anatomical basis of 
the phenotype is the same. We have shown that the critical stage in the aetiology of the 
phenotype occurs prior to cartilage differentiation and even mesenchyme condensation. 
Unfortunately, no embryonic stages of Alx4/Cart1 double mutants have been described (Qu et 
al, 1999).  
Comparison of the Alx4lst-J single mutants and Alx3/Alx4lst-J double mutants showed a strong 
exacerbation of the phenotype in craniofacial, but not in other regions. The striking Alx4 
expression pattern anteriorly in limb bud mesenchyme is also found for Alx3, so it is 
unexpected that in Alx3/Alx4lst-J double mutants no enhancement of the phenotype is seen. 
Apparently, in Alx4 mutants, Alx3 cannot compensate to a significant extent the function of 
Alx4. Strikingly, mutation of Cart1 has been shown to clearly exacerbate the polydactyly of 
Alx4 mutants (Qu et al., 1999). We have recently shown that Cart1 is expressed at a low level 
in anterior limb bud mesenchyme at E9.5-E10.5 (Beverdam, and Meijlink, 2001). It seems 
contradictory that low expression of Cart1 has more impact than that of Alx3; this paradox 
may be solved by taking into account possible specific functional properties of heterodimers 
likely formed by Alx3, Cart1 and Alx4 with each other and with other paired-related 
homeodomains (see Qu et al., 1999; Tucker and Wisdom, 1999). It remains possible that in yet 
to be bred Alx3/Alx4/Cart1 triple mutants preaxial polydactyly is further aggravated. The 
expression patterns of Alx3, Alx4 and Cart1 do not straightforwardly suggest an explanation for 
Alx3 being apparently more important in the cranium than in the limbs. This explanation 
should perhaps be sought for in differences in interactions with other genes in these areas.  
The only defect outside the skull exclusively found in the double mutant was the truncation of 
the clavicle. We previously noted Alx3 expression in the developing clavicle (shown in Ten 
Berge et al., 1998a; Beverdam unpublished). The embryological origin of the clavicle is 
obscure, but recent evidence suggests that there is some neural crest contribution to the 
clavicle, in particular the site of the attachment point for the cleidohyoid muscle (McGonnell et 
al., 2001). This suggests that the lost piece of the clavicle is at least partly neural crest derived. 
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It is striking that the function of Alx3 is almost exclusively manifest in the craniofacial areas 
where it appears to control morphogenesis of neural crest derived skeletal elements, and that 
this exception concerns a structure also linked to neural crest derived mesenchyme. It should 
be noted that the clavicle, the only remaining dermal bone of the mouse pectoral girdle, 
evolved originally as part of the head (discussed in McGonnell et al., 2001; Torrey, 1978) 
As Alx3 is highly expressed in the body wall, gastroschesis was expected to increase in double 
mutants, but no significant differences in penetrance or severity were observed. It should be 
noted that a quantitatively accurate comparison of phenotypes is hampered by the 
heterogeneous genetic background of the mice used for the analysis and the sensitivity of Alx4 
mutations for genetic background effects (Forsthoefel, 1968).  
The data discussed here indicate that Alx3, Alx4 and Cart1 constitute a distinct subgroup of 
genes sharing identical or very similar roles in the patterning of the facial primordia, in 
particular the nasal process. A second subgroup of aristaless-like genes consists of Prx1 and 
Prx2, which share to some extent the characteristics of structure and expression of the Alx3/4 
and Cart1 genes, but have functions that are primarily vital to correct patterning of the 
mandibular arch and consequently the formation of the jaws. 
 
Alx3 and Alx4 are required for proper outgrowth of the nasal processes 
We determined that the abnormalities in Alx3/Alx4lst-J double mutant embryos first become 
obvious around E10.5 in development, when the nasal processes become prominent structures. 
In double mutant embryos of E10.5, the nasal processes develop too wide apart and therefore 
fail to fuse at around E11.5, eventually causing a wide midline cleft by the time of birth. The 
crucial process of fusion of the facial primordial processes depends heavily on their proper 
outgrowth and morphogenesis. A lack of critical mass, or their abnormal position is likely to 
jeopardise the fusion process (discussed by Thorogood, 1997).  
Within the nasal processes most structures including the nasal cavities continue to develop in a 
relatively normal way, suggesting that most morphogenetic processes that regulate 
proliferation and differentiation of cells in the nose region do not depend on Alx3 or  
-4. To obtain clues at a molecular level on the nature of the defects, and in the hope of 
identifying target genes, we studied the expression pattern of several genes known to have 
distinct expression patterns in the facial regions, generally with negative results. Shh, that has 
been implicated in the outgrowth of facial processes (see Hu and Helms, 1999) is expressed in 
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normal embryos in a restricted pattern in the facial ectoderm covering the frontonasal and the 
medial nasal processes, and Ptc, a direct downstream Shh target, is expressed in ectoderm as 
well as mesenchyme underlying Shh expressing ectoderm. We found that in double mutant 
embryos of E10.5, but not at earlier stages, the region of ectodermal cells expressing Shh had 
expanded and Ptc expression in ectoderm and mesenchyme had changed accordingly. As the 
aberrant expression seems to occur only after the emergence of anatomical abnormalities, it 
appears that this expansion is a result rather than a cause of the malformations, and there is no 
reason to suggest that Shh is a specific target of Alx genes. Conceivably, the ectopic Shh 
expression from E10.5 onwards contributes to the aetiology of the phenotype.  
 
Alx3, Alx4 and Cart1 and apoptosis 
To understand at a cellular level the basis of the aberrant anatomy of E10.5 double mutants, we 
analysed cellular processes underlying growth of the nasal prominences by measuring 
proliferation and cell death patterns in embryos of these and earlier stages. We could not detect 
significant differences in proliferation indicating that the defects are not caused by proliferation 
defects. We cannot, however, exclude that changes in proliferation too subtle to be detected in 
our assays do account for significant morphological defects.  
In double mutant embryos of E10.0, but not at earlier or later stages, we did detect apoptosis in 
a very restricted region in the mesenchyme of the outgrowing frontonasal process where in 
control embryos of the same developmental stage no or very little apoptosis was detected. 
Apoptosis in double mutants was restricted to a region located dorsally within the process 
where Alx3 and Alx4 are both expressed. Lineage studies performed by McGonnell et al. 
(1998) suggest that this region will contribute to the medial nasal processes. It is conceivable 
that local cell death in an outgrowing process leads to its subsequent malpositioning and 
therefore that the aberrant apoptosis seen in the Alx3/4 mutant is likely to be in part responsible 
for the later defects. It remains currently unclear which pathway links the expression of these 
transcription factors to the process of apoptosis. A causal link between aristaless-related genes 
and regulated cell death is not without precedent. In Cart1 mutants, 70% of E8.75 embryos 
have an anterior neural tube closure defect, which appears to result from increased cell death in 
the mesenchyme surrounding the forebrain vesicles (Zhao et al., 1996). These results suggest 
that the Alx/Cart subgroup regulates craniofacial patterning by mechanisms that involve 
control of cell survival.  
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Hierarchy of genes controlling craniofacial development 
Our understanding of the molecular basis of craniofacial patterning is rapidly expanding. From 
gastrulation onwards Hox genes pattern the embryo along the anteroposterior axis from 
posterior up to the hindbrain regions. Formation and regionalisation of more rostral head 
structures, on the other hand, is dependent on genes like Otx1 and –2 and Emx1 and –2, which 
are expressed in nested patterns in mid- and forebrain prior to and during cephalic neural crest 
cell migration (see for reviews e.g. Kuratani et al., 1997; Cecchi et al., 2000). These genes may 
to some extent be responsible for determining genetic identity and preprogramming of these 
neural crest cells, which ultimately will populate the branchial arches and the frontonasal 
process. In a genetic hierarchy that appears to regulate craniofacial patterning, downstream 
from these neural genes other gene families including those related to Distal-less and aristaless 
have local functions in patterning neural crest-derived mesenchyme. It appears that the two 
subgroups of aristaless-like genes that we distinguish exercise their function on different but 
slightly overlapping complementary antero-posterior levels. The most important defects in Prx 
mutants are in the derivatives of the distal mandibular arch that is populated by neural crest 
derived from the anterior hindbrain (Ten Berge et al., 1998; Lu et al., 1999a). In contrast Alx3, 
Alx4 and Cart1 control patterning of the medial regions of the anterior skull base and of the 
nose and upper jaw regions (Qu et al., 1999, this paper); these structures derive from midbrain 
neural crest. In agreement with this, Otx2 heterozygous mutants have defects in similar regions 
of the anterior skull base and distal jaws (Kuratani et al., 1997). In future research we will test 
our hypothesis that Alx and Prx genes are directly or indirectly regulated by Otx2 and a 
rhombomere 1 and 2 specific gene like Gbx2, respectively (Wassarman et al., 1997). 
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Summary 
Alx3, Alx4 and Cart1 are aristaless-related homeobox genes that are expressed in overlapping 
patterns in the mesenchyme of the limbs, craniofacial primordia and bodywall. Cart1 is also 
expressed in the sclerotomes. Alx4 mutants have preaxial polydactyly of all four limbs, mild 
craniofacial abnormalities and body wall defects, Cart1 mutant mice have severe craniofacial 
abnormalities. They lack the skull vaults and have additional abnormalities in the facial 
skeleton (Zhao et al., 1996; Qu et al., 1997). Alx3 mutant mice do not have any detectable 
abnormalities (Beverdam et al., in press). Numerous studies show that highly related genes 
frequently have overlapping functions. This implies that to fully explore the functions of a gene 
family using knock-out studies, the generation of compound mutant genotypes is required. To 
study the functions of Alx3, Alx4 and Cart1 during skeletogenesis we have therefore generated 
Alx3/Cart1 double mutant mice and Alx3/Alx4/Cart1 triple mutant mice. 
In Alx3/Cart1 and Alx3/Alx4/Cart1 compound mutant skeletons we observed abnormalities of 
the craniofacial skeleton and limbs, including split nose regions and preaxial polydactyly. The 
penetrance of these phenotypes increased with increasing gene doses. In addition, we also 
found many novel and unexpected defects in Cart1 single, Alx3/Cart1 double and 
Alx3/Alx4/Cart1 triple mutant mice in the appendicular and axial skeletons. These included 
preaxial hindlimb polydactyly, ribcage abnormalities and a reduction of the scapula in Cart1 
mutants, protrusions on the postaxial side of the forelimb in Alx3/Cart1 double mutants and 
abnormalities of the pelvic girdle in Alx3/Alx4/Cart1 triple mutant skeletons. Our results 
clearly show that Alx3, Alx4 and Cart1 have overlapping functions during development of the 
craniofacial, appendicular and axial skeleton and that the contribution of individual gene 
functions to the development of particular structures may vary.  
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Introduction 
The vertebrate skeleton originates from multiple embryonic sources. The axial skeleton, 
consisting of the vertebrae and the ribcage is largely formed by the somites. The sternum is 
entirely derived of lateral plate mesoderm (Chevallier, 1977). Under the influence of Shh 
signalling from the notochord and floorplate, the ventral region of the somites differentiates 
into the sclerotome, from which the skeletal elements of the vertebrae and ribs derive. The 
dorsal region differentiates into the dermomyotome, which forms the dermis and the axial 
musculature (Johnson et al., 1994; Fan and Tessier-Lavigne, 1994). The skeleton of the limbs 
originates from lateral plate mesoderm. The lateral plate mesoderm grows out under the 
influence of two interdependent signalling centers (Laufer et al., 1994; Niswander et al., 1994). 
Fibroblast growth factors (Fgfs) are expressed in the apical ectodermal ridge (AER) and 
according to the "progress zone" model, they keep the underlying mesenchymal cells in a 
proliferative state (Summerbell et al., 1973; Niswander et al., 1993; Fallon et al., 1994; 
Crossley et al., 1996). Sonic hedgehog (Shh), on the other hand, is expressed by the 
mesenchymal cells of the zone of polarizing activity (ZPA), which controls  antero-posterior 
(AP) patterning of the limbs (Riddle et al., 1993). The craniofacial skeleton is made up of 
neural crest derived mesenchyme that originates from fore-, mid- and hindbrain regions and 
populates the craniofacial primordia, which consist of frontonasal process and branchial arches. 
The neural crest derived mesenchyme proliferates under the influence of signals from the 
epithelium. Coordinate outgrowth and remodelling of the primordia ultimately results in the 
formation of the craniofacial skeleton (Wedden et al., 1987; Richman and Tickle, 1992; 
reviewed in Thoroughgood, 1997). 
Two major modes of ossification exist. Most of the appendicular, axial and craniofacial 
skeleton forms by endochondral ossification. This type of ossification results in mesoderm and 
mesenchyme condensations giving rise to cartilaginous structures. These structures are 
populated by osteoblasts and osteoclasts that are brought in by invading blood vessels and are 
responsible for replacement of the cartilage matrix by bone tissue and bone remodelling. Some 
bones of the pectoral girdle and the cranial vaults, however, are formed by intramembranous 
ossification, during which the mesenchymal cells condensate and directly give rise to bone.  
Homeodomain proteins have important functions during embryonic development. They can be 
grouped into several classes based upon sequence similarities. Aristaless-like homeodomain 
proteins have a Paired-like homeodomain, but lack the Paired-domain. However, they share a 
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region of 16 highly conserved amino acids at their C-terminal end, the so-called aristaless-
domain. The genes encoding them can be grouped in three subgroups. Group I contains genes 
that are expressed predominantly in mesenchymal tissues, Group II contains genes that are 
mainly expressed in the central nervous system and Group III genes encode the Pitx genes that 
encode Paired/K50 homeodomain proteins (Meijlink et al., 1999). We are mostly interested in 
group-I aristaless-related genes (Alx3, Alx4, Cart1, Prx1, Prx2 and Prx3) and their functions 
during skeletal development. They are expressed in overlapping patterns in the mesenchyme of 
limb and craniofacial regions and single and double mutant mice display abnormalities in the 
craniofacial and limb skeleton (Zhao et al., 1994; Leussink et al., 1995; Zhao et al., 1996; Lu et 
al., 1999a,b; ten Berge et al., 1998a,b; Qu et al., 1997, 1999; Beverdam et al., in press; 
Beverdam and Meijlink, 2001). Alx4 deficient mice and lst mice, in which the Alx4 gene is 
disrupted, have preaxial polydactyly of all four limbs and mild abnormalities of the skull base 
and parietal vaults (Forsthoefel, 1963; Qu et al., 1997; Qu et al., 1999). Cart1 mutant mice 
display severe craniofacial abnormalities. They lack most of the skull vaults and have 
abnormalities in the cranial base and facial skeleton (Zhao et al., 1996). Interestingly, the 
acrania phenotype can be suppressed by treatment of pregnant mothers with folic acid. Alx3 
mutant mice, on the other hand, display no obvious abnormalities (Beverdam et al., in press). 
They are born alive, breed normally and give rise to healthy offspring. Since Alx3 and Cart1 
are highly related genes that are co-expressed in mesenchymal tissues, these genes might share 
overlapping functions during skeletal development. In the present study these potential 
overlapping functions were analysed by generation of Alx3/Cart1 and Alx3/Alx4/Cart1 
compound mutant mice. We show that these mice have enhanced and novel abnormalities in 
the development of the appendicular, craniofacial and axial skeleton.  
 
Material and Methods 
Mice: Alx3 mutant mice were generated in our lab (Beverdam et al., in press). Alx3 mutant 
mice were crossed with CMV-Cre transgenic mice (Dupé et al., 1997; gift of M. LeMeur and 
P. Chambon) to remove the pGKTKNEO cassette from the mutant Alx3 locus, generating 
Alx3
  	

 offspring. Cart1 mutant mice were obtained from B. deCrombrugghe, Houston, 
TX. Both mutants were intercrossed to obtain double mutants. The lstJ mutant was obtained 
from the Jackson lab. This mutant has a 16-bp deletion in the homeobox of the Alx4 gene, 
resulting in loss of function (Qu et al., 1999). All experiments were conducted under the 
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approval of the animal care committee of the K.N.A.W. (Royal Dutch Academy of Arts and 
Sciences). 
Genotyping: Genotyping was done using PCR analysis on tail tip or kidney DNA. 
Amplification of 326bp of the Alx3 wild type allele was done by using; 5’-
gaggctcaagaacaaggaagga-3’ (forward primer) and 5’-ctaggagcaggtcagagcaggaag-3’ (reverse 
primer). Amplification of 821bp of the LacZ gene by using 5’-tcgagctgggtaataagcgttggcaat-3’ 
(forward primer) and 5’-agaccaactggtaatggtagcgac-3’ (reverse primer) was done to identify the 
recombined mutant Alx3 locus. Amplification of 500bp of the Cart1 wild type allele was done 
using 5’-aggaagttggcagacgaataaag-3’ (forward primer and 5’-agccatttcgctgccacgtac-3’ (reverse 
primer). Amplification of 410bp of the Cart1 mutant locus was done with primers directed 
against Neo sequences: 5’-actgggcacaacagacaatcg-3’ (forward primer) and 5’-
cgtccagatcatcctgatcga-3’ (reverse primer). The Neo-primer set was also used to identify 
Alx3
     

 mice. Either 340 bp of the wildtype Alx4 locus or 324 bp of the mutant Alx4 locus 
was amplified using: 5’-caagccccctggaaaagacc-3’ (forward primer) and 5’-
ggtacattgagttgtgctgtcc-3’ (reverse primer, Qu et al., 1998). To distinguish these products they 
were restricted with PvuII and the products were separated on a 3% agarose gel. The wildtype 
locus produces a 195-bp product and the mutant locus a product of 179 bp. 
Skeletal staining: Skeletal staining was done according to standard methods (Fromental-
Ramain (IGBMC, Strabourg)). 
 
 Results 
Generating Alx3/Cart1 double and Alx3/Alx4/Cart1 triple mutant mice 
Alx3, Alx4 and Cart1 are highly related genes expressed in overlapping patterns during 
embryonic development (Beverdam and Meijlink, 2001). Loss-of-function studies reveal that 
they have important roles during patterning of craniofacial and limb regions (Forsthoefel, 
1963; Zhao et al., 1996; Qu et al., 1997; Beverdam et al., in press). To further explore the 
functions of Alx3, Alx4 and Cart1 during skeletogenesis and to overcome potential functional 
redundancy, we generated Alx3/Cart1 and Alx3/Alx4/Cart1 compound mutant mice.  
Alx3+/-/Cart1+/- and Alx3+/-/Alx4+/- double heterozygous mice did not display any abnormalities 
and were intercrossed. Compound mutants were born at expected Mendelian ratios. However, 
Alx3+/+/Cart1-/- single mutants, Alx3-/-/Cart1+/-, Alx3+/-/Cart1-/- and Alx3-/-/Cart1-/- double 
mutants, and Alx3+/-/Alx4+/-/Cart1+/- and all Alx3-/-/Alx4+/-/Cart1+/- triple mutant mice died a 
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few hours after birth with air in their intestines and no milk in their stomachs. They display 
abnormalities of limbs and crania. Most strikingly, many compound mutant mice displayed a 
cleft nose region. Only two out of twelve triple heterozygous mice survived.  
  
Alx3, Alx4 and Cart1 interact synergistically to pattern the craniofacial 
region 
We performed skeletal analysis of Alx3/Cart1 double and Alx3/Alx4/Cart1 triple mutant 
newborn skulls (see Fig. 4.1). In Alx3/Cart1 double mutant mice the craniofacial phenotype 
appeared to depend on the number and the identity of the alleles being removed. In 
Alx3+/+/Cart1-/- mice the phenotype was weakest, with abnormalities of the posterior palatine 
and surrounding bones. The phenotype became progressively stronger in Alx3-/-/Cart1+/-, 
Alx3+/-/Cart1-/- and Alx3-/-/Cart1-/- double mutant mice (see Fig. 4.1), where most of the 
prechordal skeleton was strongly affected. We did not observe acrania in Alx3+/+/Cart1-/- as 
was previously described and neither in Alx3+/-/Cart1-/- and Alx3-/-/Cart1-/- mutant newborn 
mice (Zhao et al., 1996). This is probably due to variations in genetic background.  
In 100% of the Alx3+/+/Cart1-/- newborn skulls the palatine shelves are cleft, the presphenoid is 
malshaped and both maxillary halves are wider apart than in wildtype mice (see Fig. 4.1). 
Furthermore, the shape of the premaxilla appears abnormal and in 50 % of the Alx3+/+/Cart1-/-    
newborns the distal end of the mandible is slightly truncated (see Table 1). In Alx3-/-/Cart1+/- 
newborn mice the abnormalities extend to the posterior nasal capsule with complete penetrance 
(see Table 1). In 50% of these mice the anterior nasal tip is split as well. Their palatine is cleft, 
the presphenoid is malformed and the nasal septum is posteriorly split. Both halves of the 
maxilla are wider apart, but the premaxilla is only slightly affected (see Fig. 4.1). The lower 
jaw is distally truncated in only 9% of the analysed Alx3-/-/Cart1+/- skulls (see Table 1). 
A more severe phenotype was seen in Alx3+/-/Cart1-/- mutant skulls, which all have strongly 
reduced frontal and nasal bones.  They have cleft palatines, no identifiable presphenoid bone 
and the nasal septum is more extensively affected: in all cases the nasal tip is split both 
posteriorly and anteriorly. Furthermore, the maxillary halves are wider apart and the premaxilla 
is shorter and severely distorted. All Alx3+/-/Cart1-/- mutants have a distally truncated mandible 
(see Fig. 4.1 and Table 1).  
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Alx3 +/- /Cart1 +/+ 
Alx3 +/+ /Cart1 -/- 
Alx3 -/- /Cart1 +/- 
Alx3 +/- /Cart1 -/- 
Alx3 -/- /Cart1 -/- 
Dorsal view 
+ vaults 
Dorsal view 
- vaults 
Ventral view 
- vaults 
Dorsal view 
mandible 
Alx3 -/- /Cart1 +/+ 
Alx3 +/- /Alx4 +/- /Cart1 +/- 
Alx3 -/- /Alx4 +/- /Cart1 +/- 
Figure 4.1: Skeletal abnormalities in newborn skulls of Alx3/Cart1 double and Alx3/Alx4/Cart1
triple mutant mice. Genotypes are indicated in figure. First column shows dorsal views on the skulls; 
the second column shows dorsal views with vaults removed; the third column shows a ventral view 
with mandible removed and the fourth column shown dorsal view on dissected mandible.  
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 The phenotypic defects are even stronger in Alx3-/-/Cart1-/- skulls. In all double homozygous 
mutants the nasal and frontal bones are severely reduced and defects in the brain case result in 
reduction of squamosal and alisphenoid bones. The maxillary region comprising the palatine 
shelves and the maxillaries are strongly malformed and no distinct structures are apparent. 
Both halves of the nasal capsule are wide apart and severely malformed. The premaxilla is 
severely disrupted and the mandible is reduced severely distally. This reduction causes a 
complete loss of incisors (see Fig. 4.1 and Table 1). 
 
 
Table 1: Cranial abnormalities in Alx3/Cart1 double and Alx3/Alx4/Cart1 triple 
mutant newborn mice 
Lower jaw Cleft palatine shelves Split nasal septum Genotype Number 
analysed 
# # % # % # % 
Alx3-/-/Cart1+/+ 22 0 0 0 0 0 0 
Alx3+/+/Cart1-/- 10 5 50 10 100 0 0 
Alx3-/-/Cart1+/- 22 2 9 22 100 22 100 
Alx3+/-/Cart1-/- 31 31 100 31 100 31 100 
Alx3-/-/Cart1-/- 17 17 100 17 100 17 100 
Alx3+/-/Alx4+/-/Cart1+/- 10 7 70 6 60 8 80 
Alx3-/-/Alx4+/-/Cart1+/- 7 7 100 7 100 7 100 
 
 
In Alx3+/-/Alx4+/-/Cart1+/- triple heterozygote mice the cranial abnormalities are very variable. 
Mice with very weak phenotypes viable. Their nasal septum and palatal shelves are hardly or 
possibly not affected. Therefore, the defects are milder compared to the weakest though always 
lethal phenotypes of Alx3-/-/Alx4+/- and Alx3-/-/Cart1+/- mice. Triple heterozygous mice with 
intermediate phenotypes generally have a posteriorly split nasal septum, which goes mostly 
together with cleft palatal shelves (see Fig. 4.1 and Table 1). Triple heterozygous mice 
displaying the strongest phenotypes have completely split nasal septa, cleft palatine shelves 
and disrupted anterior skull base elements. Triple heterozygote mice with intermediate or 
strong phenotypes also display malformed maxillary and premaxillary regions. Furthermore, 
the dentaries are truncated in 70% of all cases (see Fig. 4.1 and Table 1). All Alx3-/-/Alx4+/-
/Cart1+/- mutants have very severe clefting of palatine and nose regions, strongly disrupted 
maxillary and premaxillary regions and truncated lower jaws. The cranial phenotype is, 
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stronger compared to Alx3-/-/Alx4+/-/Cart1+/+, Alx3-/-/Alx4+/+/Cart1+/- and Alx3+/-/Alx4+/-
/Cart1+/- mice and similar to Alx3-/-/Alx4-/- and Alx3-/-/Cart1-/- mutant mice. The achordal 
skeleton, the hyoid skeleton and the otic capsule were not affected in Alx3/Cart1 and 
Alx3/Alx4/Cart1 compound mutant mice (see Fig. 4.1 and not shown). In summary these 
studies show that Alx3, Alx4 and Cart1 work synergistically to pattern the palatine and anterior 
skull base region, the nose and distal lower jaw.  
 
Abnormalities in Alx3/Cart1 double mutant limbs  
Alx3 and Cart1 are expressed in the outgrowing limb buds, but Cart1 and Alx3 mutant mice 
have no limb abnormalities (Zhao et al., 1996; Beverdam et al., in press, Beverdam and 
Meijlink, 2001). We unexpectedly found that one out of ten Cart1 homozygous mutant mice 
did have preaxial hindlimb polydactyly as revealed by the presence of one extra digit with 
posterior character (see Fig. 4.2D and Table 2). This may be due to the variable genetic 
background. Alx3/Cart1 double mutants lacking three or more alleles display a higher 
incidence of hindlimb polydactyly with variable expressivity. In all cases one extra digit was 
observed ranging from a complete digit with 3 phalanges to a simple bifurcation of digit 1. 
Preaxial hindlimb polydactyly was observed in 57% of the Alx3-/-/Cart1+/- mutants, 10% of the 
Alx3+/-/Cart1-/- mutants and 77% of the Alx3-/-/Cart1-/- mutants (see Fig. 4.2E, G, I and Table 
2).  
In addition, we observed an abnormality on the postaxial side of the forelimb autopod in a 
small number of double mutants. 2 of 31 Alx3-/-/Cart1+/- mice and 2 of 17 Alx3-/-/Cart1-/- mice 
show a postaxial protrusion on the forelimb autopod (see Fig. 4.2O, P and Table 2). These 
protrusions sometimes contain a very small cartilaginous element, but often they consist of soft 
tissue only (see Fig. 4.2P and not shown). In none of the Alx3/Cart1 double mutants 
abnormalities were detected in zeugopods or stylopods of fore- and hindlimbs (see Fig. 4.2E, 
G, I and not shown) and the deltoid crest on the humerus, which is sometimes absent in Alx4 
mutants, is normally formed in all compound mutants.  
In the triple mutant background we detected preaxial polydactyly in both hindlimbs and 
forelimbs and the hindlimb polydactyly occurred with a higher penetrance compared to in the 
Alx3/Cart1 double mutants. The polydactyly involves the presence of maximally one extra 
digit of which the shape varied between a complete extra digit articulating with the carpals to a 
small digit fused to digit 1 (see Fig. 4.2K, L, M and N). Preaxial hindlimb polydactyly was 
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observed in all triple heterozygote and Alx3-/-/Alx4+/-/Cart1+/- mice, whereas preaxial forelimb 
polydactyly was detected in 11% of the triple heterozygote mutants and in 17% of the Alx3-/-
/Alx4+/-/Cart1+/- mutants (see Fig. 4.2K, L, M, N and Table 4). In addition, in 43% of the Alx3-/-
/Alx4+/-/Cart1+/- mice the tibia is strongly reduced and the fibula is curved (see Fig. 4.4E, F and 
Table 5). The deltoid crest is normally present in Alx3/Alx4/Cart1 triple mutant mice.  
In conclusion: in both Alx3/Cart1 and Alx3/Alx4/Cart1 double and triple mutant mice we 
observed abnormalities in the autopods of fore- and hindlimbs and hindlimbs appeared more 
susceptible than the forelimbs. The analyses of the Alx3/Cart1 double mutant limbs show that 
limb patterning is strongly affected by mutations in Cart1 but only moderately by mutations in 
Alx3. Apparently, Alx3, Alx4 and Cart1 have functions in patterning the autopods of both fore- 
and hindlimbs, but the contributions of individual genes to the phenotype of compound mutants 
varies.  
 
 
 
Table 2: Limb abnormalities in Alx3/Cart1 double mutant newborn mice 
 
*1: 9 newborn included in analysis of hindlimb abnormalities 
Preaxial hindlimb polydactyly Genotype Number 
1x 2x % 
Alx3-/-/Cart1+/+ 22 0 0 0 
Alx3+/+/Cart1-/- 10 1 0 10 
Alx3-/-/Cart1+/- 22 7 5 57 
Alx3+/-/Cart1-/- 31 3 0 10 
Alx3-/-/Cart1-/- 17 3 7 77 
Alx3+/-/Alx4+/-/Cart1+/- 10 3*1 6*1 100*1 
Alx3-/-/Alx4+/-/Cart1+/- 7 0 7 100 
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Figure 4.2: Limb 
abnormalities in 
Alx3/Cart1 double and 
Alx3/Alx4/Cart1 triple 
mutant mice. Genotypes 
are indicated in figure. 
Panels A, C, G, I, K, M 
show forelimbs with 
pectoral girdle attached, 
B, D, F, H, J, L and N 
show autopods of 
hindlimbs. Arrows in C, 
G and I point towards 
malformed scapula. 
Asterisks in F, H, J, L 
and N point towards 
extra digit. O and P show 
the postaxial protrusion 
on the forelimb of an 
Alx3-/-/Cart1-/- mouse. 
Asterisks in O indicate 
postaxial protrusion and 
arrow in P points 
towards cartilaginous 
nodule present at 
postaxial side of the 
forelimb autopod. 
 
 
Postaxial 
protrusion 
Postaxial cartilage 
nodule 
 
 Skeletal defects in Alx3/Cart1 double and Alx3/Alx4/Cart1 triple mutants 
 75
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
C
Alx3-/-/Cart1+/-
A
Control
B
Alx3+/+/Cart1-/-
*
D
Alx3+/-/Cart1-/-
*
Alx3-/-/Cart1-/-
E
Alx3-/-/ Alx4+/-/ Cart1+/-
G
Alx3+/-/ Alx4+/-/ Cart1+/-
F
 
Figure 4.3: Rib cage abnormalities in Alx3/Cart1 double and 
Alx3/Alx4/Cart1 triple mutant mice. Genotypes are indicated in 
figure. Arrows point towards xyphoid process of the sternum. 
Asterisks in B and D mark protrusions at the xyphoid process of 
the sternum. White arrowhead point towards point of fusion of 
two ribs. 
 
A B
C
Alx3-/-/ Alx4+/-/ Cart1+/-Control
D
* *
* *
E F
Figure 4.4: Skeletal abnormalities in 
Alx3/Alx4/Cart1 triple mutant mice. Genotypes are 
indicated in figure. Panel A and B show dorsal 
views on the ribcages of control and triple newborn 
mutants, respectively. Asterisks in B mark abnormal 
thirteenth rib. C and D show ventral views on pelvic 
girdle of control and triple mutant newborn mouse, 
respectively. Asterisks in D mark truncated pubic 
bone. E and F show hindlimb zeugo- and autopods 
of control and triple mutant newborn mouse, 
respectively. Arrow in F point towards malformed 
tibia. 
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Other skeletal abnormalities 
Alx3 and Cart1 are both expressed in lateral plate mesoderm of the body wall and Cart1 is also 
expressed by the sclerotome (Zhao et al., 1994; ten Berge et al., 1998a). In Alx3/Cart1 double 
mutants, defects are observed in structures derived from these tissues, namely in the sternum, 
which is derived from lateral plate mesoderm, and in the scapula. The origin of the scapula is 
not unambiguously understood, but the somitic and lateral plate mesoderm probably both 
contribute to its formation (see Fig. 4.2A, C, E, G and I, and Fig. 4.3A-F; Le Douarin, 1969; 
Chevallier, 1977; Burke et al., 1991). 
In 100% of the Alx3+/+/Cart1-/-, Alx3+/-/Cart1-/- and Alx3-/-/Cart1-/- mutants the blade of the 
scapula rostral from the spine is absent (see arrows in Fig. 4.4C, G, I and Table 3). The rest of 
the shoulder girdle is unaffected. This defect was not described before for the Cart1 single 
mutant mice. In Alx3-/-/Cart1+/- mutants this defect was observed in only 9% of the newborns 
(see Table 3). Sternal abnormalities were observed mostly in the xyphoid process, which was 
shorter and broader and often malshaped. In a few cases defects were also observed more 
anteriorly in the sternebrae, which appeared irregular in shape. In Alx3+/+/Cart1+/-, Alx3+/-
/Cart1+/- and Alx3-/-/Cart1+/+ mutant mice the xyphoid process was normal, but we found 
abnormalities in Alx3+/+/Cart1-/- mutants with complete penetrance (see Fig. 4.3B and Table 3). 
This defect was not reported for the Cart1 mutant. Also Alx3+/-/Cart1-/- and Alx3-/-/Cart1-/- 
double mutants have sternal defects with full penetrance, whereas in only 18% of the Alx3-/-
/Cart1+/-  mutants defects were detected in this region (see Fig. 4.3C, D, E and Table 3). In 1 
out of 17 Alx3-/-/Cart1-/- mutants the entire ribcage was severely affected. The sternum was 
very irregular in shape and rib fusions were observed (see arrowhead in Fig. 4.3E). 
In the triple mutant background, we only found ribcage abnormalities in Alx3-/-/Alx4+/-/Cart1+/- 
mice: 43% had reduced sternums and in one mouse the 13th rib was abnormal (see Fig. 4.4G). 
We also detected abnormalities in the pectoral and pelvic girdles of Alx3-/-/Alx4+/-/Cart1+/- 
mice: 29% of the mice have malformed clavicles and in 57% of the mice the pubic bone was 
severely reduced (see Fig. 4.4C, D and not shown). In contrast, no abnormalities affecting the 
scapula were observed (see Fig. 4.2M). We previously found reduced clavicles in Alx3/Alx4 
double mutants (Beverdam et al., in press). Reduction of the pubic bone, on the other hand, 
was not previously observed in Alx3, Alx4 and Cart1 single or double mutants. These results 
indicate that Alx3, Alx4 and Cart1 have overlapping functions during patterning of the ribcage 
and the pelvic girdle. Moreover, Alx3 and Cart1 also contribute to formation of the scapula.  
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Table 3: Scapular and sternal abnormalities in Alx3/Cart1 double and Alx3/Alx4/Cart1 
triple mutant newborn mice 
 Scapular abnormalities Sternal abnormalities 
Genotype Number of 
newborns 
analysed 
# with 
malformed 
scapula 
% with 
malformed 
scapula 
# with sternal 
abnormalities 
% with sternal 
abnormalities 
Alx3-/-/Cart1+/+ 22 0 0 0 0 
Alx3+/+/Cart1-/- 10 10 100 10 100 
Alx3-/-/Cart1+/- 22 2 9 4 18 
Alx3+/-/Cart1-/- 31 31 100 29 94 
Alx3-/-/Cart1-/- 17 17 100 17 100 
Alx3+/-/Alx4+/-/Cart1+/- 10 0 0 1 10 
Alx3-/-/Alx4+/-/Cart1+/- 7 0 0 3 43 
 
Table 5: Skeletal abnormalities in Alx3/Alx4/Cart1 triple mutant mice 
% Tibial hypoplasia Pubic abnormalities 
% 
Clavicular 
abnormalities (%) 
genotype Analysed 
# 
# % # % # % 
Alx3+/-/Alx4+/-/Cart1+/- 10 0 0 0 0 0 0 
Alx3-/-/Alx4+/-/Cart1+/- 7 3 43 5 71 2 29 
 
Discussion 
Alx3, Alx4 and Cart1 are highly related genes co-expressed in the mesenchyme of different 
structures and share functions during skeletogenesis as shown by analyses of single and double 
mutants (Forsthoefel, 1969; Zhao et al., 1996; Qu et al., 1997, Qu et al., 1999; Beverdam and 
Meijlink, 2001, Beverdam et al., in press). To determine the functions of Alx3, Alx4 and Cart1 
during skeletal development, we generated Alx3/Cart1 double and Alx3/Alx4/Cart1 triple 
mutant mice. As expected, Alx3/Cart1 double mutants and Alx3/Alx4/Cart1 triple mutants 
display many defects similar to those of Alx3/Alx4 and Alx4/Cart1 double mutant mice (Qu et 
al., 1999, Beverdam et al., in press). In both double and triple mutants the severity of defects 
depends on gene dosage. Overall, loss of two functional alleles results in no or relatively mild 
abnormalities, loss of three alleles results in stronger defects and loss of four alleles in the 
severest defects. In addition, defects in Cart1 single mutant mice were observed and additional 
defects in the craniofacial, appendicular and ribcage skeleton of Alx3/Cart1 double and 
Alx3/Alx4/Cart1 triple mutant mice.  
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The results show that Alx3, Alx4 and Cart1 have overlapping functions in patterning of the 
craniofacial, appendicular and axial skeleton. Generally it can be said that the contributions of 
Alx4 and Cart1 are more important than the one of Alx3. These results underscore the 
importance of studying the phenotypes of compound mutants to fully understand the functions 
of structurally and functionally highly related genes. 
 
Redundant functions of Alx3, Alx4 and Cart1 during craniofacial 
patterning  
Like Alx3/Alx4 and Alx4/Cart1 double mutants, Alx3/Cart1 double and Alx3/Alx4/Cart1 triple 
mutants display reduced frontal and nasal bones, cleft palatine bones and nose regions, a 
malformed anterior skull base and distally malformed mandibles. It is likely that the observed 
defects in the nose regions of Alx3/Cart1 and Alx4/Cart1 double and Alx3/Alx4/Cart1 triple 
mutants are caused by similar cellular defects in Alx3/Alx4 double mutant mice, i.e. impairment 
of outgrowth of the nasal processes probably due to cell death (Beverdam et al., in press). 
Distal truncation of their dentaries may, like in Prx1/Prx2 double mutants, be caused by 
reduced mesenchymal cell proliferation in distal mandibular processes (ten Berge et al., 2001). 
In contrast earlier studies, we do not observe acrania in our Cart1 mutant newborn mice (Zhao 
et al., 1996).  
 
Functions of Alx3, Alx4 and Cart1 in limb patterning 
Early during limb outgrowth Shh is expressed in a mesenchymal region posteriorly in the limb 
buds, the ZPA. It is responsible for correct AP patterning (Riddle et al., 1993). An anterior 
cascade of genes, including Alx4, is thought to restrict establishment of a ZPA and expression 
of Shh to posterior limb mesenchyme (Takahashi et al., 1998). Alx3 and Cart1 are highly 
related to Alx4. They are expressed anteriorly in the limb bud mesenchyme (Beverdam and 
Meijlink, 2001). Therefore they likely share similar targets and have similar functions in limb 
patterning. Accordingly, in Alx4/Cart1, Alx3/Alx4, Alx3/Cart1 and Alx3/Alx4/Cart1 compound 
mutant mice a gene dosage dependent enhancement of the preaxial polydactyly was observed 
(Qu et al., 1999; Beverdam et al., in press, this paper). An unexpected result was the preaxial 
hindlimb polydactyly in one of the Alx3+/+/Cart1-/- mutants, that has not been reported before 
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(Zhao et al., 1996). Development of polydactyly in Alx4 mutant mice strongly depends on 
genetic background as was noted by Forsthoefel in lst mice (Forsthoefel, 1968). 
 
Alx3, Alx4 and Cart1 have functions in patterning the sternum and limb 
girdles 
Alx3 and Cart1 are expressed in lateral plate mesoderm and Cart1 is also expressed in 
sclerotomal cells (Zhao et al., 1994; ten Berge et al., 1998). Alx3, Alx4 and Cart1 single and 
compound mutants have abnormalities in many structures derived from these tissues. Cart1 
single and Alx4/Cart1 and Alx3/Cart1 double mutant mice have abnormalities in the sternum, 
which is lateral plate mesoderm derived (Chevallier 1975). This defect was never reported for 
Cart1 mutants. In Alx4-/-/Cart1-/- double mutants, the sternum was always completely split, 
while the sternal defects are significantly milder in the Alx3/Cart1 double mutants (Qu et al., 
1999). The sternal abnormalities in both mutants are probably caused by a failure of the sternal 
bands to fuse, which seems to depend more on Alx4 and Cart1 than on Alx3. 
The regions of the lateral plate mesoderm, expressing Alx3, Alx4 and Cart1 and the somitic 
mesoderm, expressing Cart1, contribute to formation of the limb girdles. Indeed, Alx3, Alx4 
and Cart1 single and compound mutants have limb girdle abnormalities (Le Douarin, 1969; 
Chevallier, 1997, Burke, 1991). The clavicles of Alx3/Alx4 double and Alx3/Alx4/Cart1 triple 
mutants are shortened, the scapula is misshapen in Cart1 single and Alx3/Cart1 double mutant 
mice and the pubic bones are severely reduced exclusively in Alx3/Alx4/Cart1 triple mutants. 
The girdle regions are most likely specified earlier during development than the more distal 
limb structures. Alx3, Alx4 and Cart1 are expressed in the lateral plate mesoderm just prior to 
and during limb bud outgrowth. Later these genes are expressed proximally in the developing 
limb buds (Beverdam and Meijlink, 2001). Emx2 and Pax1 are expressed in strikingly 
overlapping patterns with Alx3, Alx4 and Cart1 in the anterior-proximal limb bud cells that 
contribute substantially to parts of the limb girdles (Timmons et al., 1994; Pellegrini et al., 
2001; Beverdam and Meijlink, 2001). Pax1 and Emx2 mutants have scapular abnormalities 
(Grüneberg, 1950; Timmons et al., 1994. Wallin et al., 1994; Pellegrini et al., 2001). In Emx2 
homozygous mutant limb buds the Pax1 expression domain is enlarged, suggesting an 
interaction between Pax1 and Emx2 (Pellegrini et al., 2001). The expression patterns of Pax1 
and Emx2 and the phenotypic abnormalities in the pectoral girdle of Pax1 and Emx2 single 
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mutants indicate a functional interaction with Alx3, Alx4 and Cart1 to pattern the limb girdles. 
It would therefore be interesting to study expression patterns of these genes in mutant mice. 
 
Group-I aristaless-related genes and the cell cycle 
This and other studies reveal a role for group-I aristaless-related genes in patterning 
craniofacial and limb regions by controlling mesenchymal cell number. In E9.0 Cart1 mutant 
embryos cell death is observed in the forebrain mesenchyme, probably causing the acrania 
phenotype (Zhao et al., 1996). Cell death in the frontonasal process of E10.0 Alx3/Alx4 double 
mutant embryos very likely underlies the split nose phenotype (Beverdam et al., in press). The 
lower jaw abnormalities of Prx1/Prx2 double mutants were shown to be caused by decreased 
proliferation rates of mesenchymal cells within the distal tip of the mandibular processes (ten 
Berge et al., 2001). The way in which aristaless-like genes control cell number seems rather 
inconsistent, i.e. either by stimulation or reduction of cell proliferation or by prevention of 
apoptosis. It is however conceivable that molecular interactions with components of the cell 
cycle underly these effects. Molecular evidence does indeed exist that Paired-like 
homeodomain proteins directly interact with retinoblastoma (pRb) family members. These 
interactions can result in repression of transcriptional activity (Wiggan et al., 1998). The pRb 
proteins negatively regulate the G1 to S phase of the cell cycle through interactions with E2F 
and other cellular proteins. Possibly, patterning is at least partly controlled by interactions of 
aristaless-related proteins with cell cycle regulatory proteins. Therefore, interactions between 
pRb and group-I aristaless-like proteins and possibly other cofactors could provide a potential 
mechanism for integrating the process of cellular proliferation with differentiation. 
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Functions of group-I aristaless-related genes during development 
As described in Chapter 2, Group-I aristaless-related genes are expressed in strongly 
overlapping patterns in the craniofacial primordia and the outgrowing limb buds (see Fig. 5.1; 
Beverdam and Meijlink, 2001).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Alx3, Alx4 and Cart1 are highly expressed in overlapping patterns in frontonasal and nasal 
processes and distally in the mesenchyme of the first and second branchial arches and in an 
anterior domain proximally in the outgrowing limb buds. Prx1 and Prx2 are expressed at 
higher levels in a broader region in the first and second branchial arches, but at lower levels in 
the frontonasal and nasal processes. In the limbs they are highly expressed in a broad region 
along the limb margin. Expression of Prx3 in the craniofacial primordia is restricted to the 
medial nasal processes and to a domain proximally in the first branchial arch. In the limbs, it is 
expressed in a domain that seems complementary to that of Prx1 and Prx2.  
The expression patterns correlate well with the abnormalities observed in single and double 
mutants (see Fig. 5.2 and 5.3). Alx4 mutants have reduced parietal vaults, abnormalities in the 
anterior skull base and preaxial polydactyly of all four limbs (Forsthoefel, 1963; Qu et al., 
1997b). Cart1 mutants were reported to lack most of their skull vaults, in addition, they have 
mild abnormalities in the facial skeleton and in the anterior skull base region. In E9.0 Cart1 
mutant embryos the anterior neural tube fails to close, which most likely is caused by mesen- 
Alx3 Alx4 Cart1 Prx1 Prx2 Prx3 
Fig 5.1: Summary of expression data of group-I aristaless-related genes in craniofacial primordia of 
E10.5 mouse embryos (upper row) and in E9.5 forelimb buds. 
Chapter 5 
 
84 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
chymal cell death in the mesenchyme overlying the forebrain vesicles (Zhao et al., 1996). In 
the genetic background of the mice used in our experiments, however, the Cart1 mutants do 
not have neural tube closure deficiencies or acrania. Alx3 single mutants also show no 
detectable abnormalities, but mutation of Alx3 in an Alx4 or Cart1 mutant background 
considerably enhances the single mutant phenotype (see Fig. 5.3; Beverdam et al., in press; 
Chapter 4 of this thesis). As I show in Chapter 3 and 4, Alx3, Alx4 and Cart1 double and triple 
mutant mice have polydactyly and strongly enhanced craniofacial abnormalities. In all mutants 
lacking three or more alleles the nose regions are cleft from nasal tip to anterior skull base 
levels and the mandible is mildly malformed (see Fig. 5.3; Qu et al., 1999; Beverdam et al, in 
press, Beverdam et al., in preparation). The severe abnormalities in the nose regions arise 
probably due to defective merging of the nasal processes, as has been convincingly shown for 
Alx3/Alx4 double mutant and Alx3/Cart1 double mutants (see Chapter 3; Verweij and 
Beverdam, unpublished results). Since Alx3, Alx4 and Cart1 are closely related genes with 
largely overlapping expression domains in the craniofacial primordia, they very likely share 
identical target genes and control similar genetic networks. Therefore, we expect that in all 
Fig. 5.2: Diagrams showing overlapping expression patterns of Alx3, Alx4, Cart1, Prx1 and Prx2 in 
craniofacial primordia of E10.5 mouse embryos (upper panels) and in E9.5 limb buds (lower panels). 
Color intensities reflect expression levels of the genes. 
Prx1 Prx2 Alx3 Cart1 Alx4 Alx3 Cart1 Alx4 
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compound mutants the cellular basis is enhanced apoptosis in a restricted region of the 
frontonasal process mesenchyme of E10.0 mouse embryos as has been shown for the Alx3/Alx4 
double mutants in Chapter 3.  
In Chapter 4, I describe that Alx3/Cart1 double mutants and Alx3/Alx4/Cart1 triple mutants 
have multiple skeletal defects affecting the skull, the appendicular skeletons and in the ribcage 
(see Fig. 5.3). Triple mutants lacking at least four alleles have abnormalities in the pelvic 
girdle, which are absent from Alx3, Alx4 and/or Cart1 single or double mutants.  
As discussed, Prx1 and Prx2 are highly related genes and are expressed in overlapping 
domains by craniofacial primordia and developing limb buds. They also have overlapping 
functions in patterning of these structures. Prx2 mutant mice do not have detectable 
abnormalities, but Prx1 mutants have defects in first and second branchial arch derivatives. 
(see Fig. 5.3; ten Berge et al., 1998b). They have cleft palatines, defects in maxilla, mandible 
and middle ear and in bones constituting the lateral skull wall. In addition, they have shortened 
zeugopods (see Fig. 5.3; Martin et al., 1995). In Prx1/Prx2 double mutants many of these 
defects are enhanced. In addition, novel abnormalities, not present in Prx1 single mutants, were 
detected in inner ear and limb autopods (see Fig. 5.3; ten Berge et al., 1998b; Lu et al., 1999b). 
The lower jaw defects were attributed to reduced proliferation of mesenchymal cells in the 
distal tips of E10.5 mandibular processes. This likely is caused by simultaneous reduction of 
Shh expression in the overlying epithelium (ten Berge et al., 2001).  
 
 
 
 
 
 
 
 
 
 
 
 
Alx3-/-/Alx4-/-
Alx4-/- Cart1-/- Prx1-/- Prx2-/-
Alx3-/-/Cart1-/- Alx4-/-/Cart1-/- Prx1-/-/Prx2-/-
Alx3-/-
Fig. 5.3: Diagrams showing summary of single and double mutant skull phenotypes of group-I 
aristaless-related genes. Grey shaded structures are affected in mutants. 
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In summary, during craniofacial development Alx3, Alx4 and Cart1 are highly expressed in 
frontonasal and nasal processes in overlapping domains, where they have overlapping 
functions in patterning of skull structures, including upper jaw and nose regions and the distal 
mandible (see Fig. 5.1, 5.2 and 5.3). They have no obvious function in patterning 2nd branchial 
arch derived structures. Prx1 and Prx2 are highly expressed by the first and second arch, where 
they have overlapping functions in patterning of more posterior skull structures, including the 
upper and lower jaw and outer, middle and inner ear structures (see Fig. 5.1, 5.2 and 5.3). In 
the developing limbs, Alx3, Alx4, Cart1 are expressed in overlapping patterns in an anterior 
proximal domain in the limb bud, whereas Prx1 and Prx2 are expressed in a broad region of 
the limb margin. Alx3, Alx4 and Cart1 regulate patterning of the autopod, whereas Prx1 and 
Prx2 pattern both auto- and zeugopods. Overall, it becomes clear that during development, 
Alx3, Alx4, Cart1, Prx1 and Prx2 have overlapping functions in patterning of structures where 
these genes are co-expressed. Alx3, Alx4 and Cart1, however, pattern more distal parts of these 
structures than Prx1 and Prx2. Based on structural data, expression patterns and gene 
functions, the group I aristaless-like genes can thus be divided into three subclasses. One 
consists of Alx3, Alx4 and Cart1 (the Alx genes) and one consisting of Prx1 and Prx2 (the Prx 
genes) and the last of mouse Prx3 and the human genes Shox and Shot. 
Double and triple mutants have, besides a strong enhancement of the single mutant phenotype, 
also "novel" defects, which are not present in either single mutant. Therefore, these loss-of-
function studies clearly demonstrate that only via generation and analysis of complex 
compound mutant mice the full range of functions of highly related genes can be studied.  
In Alx3 and Prx2 mutants, the functions of Alx3 and Prx2 are taken over by Alx4 and Cart1 or 
Prx1, respectively. This phenomenon is commonly referred to as functional redundancy. We 
appreciate the molecular basis for redundancy as regulation of the same target genes. 
Unfortunately, no in vivo data are available that support this hypothesis: besides in vitro 
evidence of Prx2 regulating promoter activity of tenascin, no direct target genes have been 
identified for aristaless-related genes thus far.  
 
Molecular basis for functional diversity of group-I aristaless-
related genes in vivo 
As described in Chapter 2, the highly related group-I aristaless-like genes can be classified in 
three subgroups, based on expression patterns and functions during embryonic development. 
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While functions of group-I aristaless-related genes strongly overlap during development of 
craniofacial and limb regions, the impact on these developmental processes strongly differs 
among the genes. Moreover, besides overlapping functions they also fulfil distinct functions 
during embryogenesis. This immediately raises the question of how we can understand this 
functional diversity. First of all, this strongly depends on where the genes are expressed. 
Unfortunately, we do not have insight into the promoter regions of these genes, which would 
reveal how their expression is regulated by upstream proteins. Regulation of direct target genes 
and downstream developmental pathways, on the other hand, relies on molecular properties of 
group-I aristaless-related proteins, thus on characteristics of their conserved domains. 
Conserved domains are often involved with protein-protein interactions, which generally have 
important consequences for protein function. Therefore, the presence or absence of interacting 
cofactors in a certain tissue are very likely to have important consequences for the development 
of such a structure. But also small structural differences within these domains may cause 
functional divergence in vivo.  
In the next sections I will discuss molecular characteristics and functions of conserved protein 
domains of group-I aristaless-related proteins. Using this knowledge I also will try to explain 
how these highly similar proteins acquire a range of distinct molecular properties, which may 
underlie their heterogeneity in function during development (for summary see Table 1). 
 
Conserved protein domains 
The aristaless domain  
In addition to the paired-type homeodomain, aristaless-related proteins contain a second 
conserved domain, the aristaless domain. This domain affects both DNA binding and 
transcriptional activity in cultured cells, dependent on binding of cofactors (see Fig. 5.4). 
Amendt et al. (1999) have shown that in the aristaless-related protein Pitx2 the aristaless 
domain modulates transcriptional activity by inter- and intramolecular interactions. Binding of 
the transcription factor Pit1 to the aristaless domain stimulates Pitx2 DNA binding and 
transcriptional activation, presumably by unmasking an activation domain in a region N-
terminal from the homeodomain. The C-terminus of aristaless-related Pitx1 was shown to bind 
the family of LIM domain-associated cofactors, P-Lim and CLIM1a (Bach et al., 1997). This 
interaction may similarly affect DNA binding and transcriptional activity of Pitx1. 
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In vitro evidence strongly supports the occurrence of intramolecular interactions within group-I 
aristaless-related proteins. The aristaless domains of Prx1 and Prx2 were also shown to inhibit 
transactivation by functioning to mask transactivating domains, but only the aristaless domain 
of Prx1 is capable of reducing DNA binding affinity (Norris and Kern, 2001a; Norris et al., 
2001b). In vitro and in vivo data of our group show that the aristaless domain of Cart1 
significantly reduces transactivation through a mechanism involving intramolecular 
interactions with the N-terminus. In contrast, the aristaless domain of Alx3 hardly affects 
transcriptional activity, which may be attributed to its very unusual structure, suggesting that it 
has lost its function (Brouwer, Wiegerinck, Ten Berge, Meijlink, in preparation).  
It has not yet been extensively studied if the aristaless domain of group-I proteins undergoes 
intermolecular interactions. In vivo, these intermolecular interactions are likely to have 
Low transactivation capacity 
Low affinity target DNA binding 
 
Cofactor binds to aristaless domain 
 
 Fig. 4: Paradigm for the multifunctional aristaless 
domain.  Cofactor binding to the aristaless domain 
prevents "masking" of transactivation domains in N-
terminal tail of aristaless-related proteins and increases 
the affinity of DNA binding. (Adapted from Amendt et 
al., 1999) 
Upon cofactor binding: 
Increased transactivation capacity 
Increased affinity target DNA binding 
 
target DNA 
target DNA 
target DNA 
aristaless domain 
cofactor 
homeodomain 
transactivation domain 
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important consequences for the regulation of target genes and downstream developmental 
processes, for this seems to depend strongly on the presence or absence of aristaless domain 
interacting cofactors. Therefore, identification of aristaless domain binding proteins may give 
important insights into how group-I aristaless-related proteins function in vivo. It is not 
unlikely that their aristaless domains interact with POU and LIM domain proteins similar to 
Pitx proteins.  
However, the characteristic of the Prx2 aristaless domain not to decrease target DNA binding 
affinity and the aberrant aristaless domain of Alx3 cause a certain degree of functional 
heterogeneity among group-I aristaless-related proteins. This heterogeneity is even further 
increased by the fact that two Prx1 splice variants exist, Prx1a and Prx1b. Prx1a contains the 
aristaless domain, whereas in Prx1b this domain is lacking. Instead it incorporates a stretch of 
18 amino acid at the C-terminal end. This differential splicing also has high impact on the in 
vitro transcriptional activity of the protein. Prx1a functions as an activator of transcription, 
whereas the Prx1b variant functions as a repressor (Norris and Kern, 2001a). In conclusion, it 
appears that in all aristaless-related proteins the aristaless domain undergoes similar 
intramolecular and probably also intermolecular interactions in vitro. In vivo these interactions 
may have important consequences for target DNA binding and regulation of target gene 
expression. The characteristic properties of the aristaless domains of Alx3, Prx1 and Prx2 
probably have important consequences for both intra- and intermolecular interactions that these 
proteins may undergo in vivo and very likely this sets them functionally apart from the other 
group-I aristaless-related proteins.  
 
The homeodomain 
Homeodomain proteins are transcription factors that bind to target DNA with their 60 amino 
acid homeodomain and regulate transcription, thereby determining which downstream 
developmental pathways are activated or repressed. An important factor controlling 
transcriptional regulation is the target specificity and/or affinity of binding of the 
homeodomain to consensus sequences in the promoter regions of target genes. Target 
specificity of homeodomain proteins strongly depends on the amino acid composition of the 
homeodomain, in particular on the identity of the residue on position 50. Moreover, it depends 
on the presence of other DNA binding domains within the protein. The Paired-type 
homeodomain has important in vitro characteristics, which may shed some light on how they 
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attain target specificity in vivo. They can homo- and/or heterodimerise in a cooperative 
manner. This relies in contrast to most other dimerising homeodomain proteins, entirely on 
residues within the homeodomain (Wilson et al., 1993). Cooperative dimerization has an 
important impact on target specificity, since the conformation of the DNA-binding complex 
varies among members of the Paired-class. This conformational specificity is conferred by the 
50th residue of the homeodomain. When this residue is a serine (S50), like in Pax-like proteins, 
the structure of the dimer is more compact. This causes it to bind with high affinity to 
palindromic target sequences spaced by two nucleotides, P2 sites. In aristaless-like proteins this 
residue is a glutamine (Q50) or a lysine (K50). Dimers composed of Q50 or K50 homeodomain 
proteins bind preferentially to sites that are spaced by three nucleotides, P3 sites. Q50 
homeodomains, however, bind to P3 sites with significantly more cooperativity than K50 
homeodomains (Wilson et al., 1993). Members of the same or different Paired-type 
homeodomain classes form heterodimeric complexes with distinct DNA binding and 
transcriptional properties in vitro. This is likely to have important consequences for regulation 
of direct target genes in vivo. Alx4 and Gsc are capable of forming homo- and heterodimers 
that display unique DNA binding properties in vitro. This implies that in vivo these dimer 
complexes are capable of discriminating between target genes (Tucker and Wisdom, 1999). 
Alx4 and Cart1 are also known to be able to form homo- and heterodimers in vitro, but it is 
unclear how this affects DNA binding and/or transcriptional activity (Qu et al., 1999). The 
dimerisation behaviour of other group-I aristaless-related proteins has never been analysed, but 
it is very likely to affect target gene regulation by group-I aristaless-related proteins in vivo.   
Besides the identity of the amino acid at position 50, residues at other conserved positions 
within the homeodomain probably also participate in determining the specificity and/or affinity 
of target recognition. Moreover they may also influence dimerisation characteristics of the 
proteins. They may for instance affect the selectivity of dimerising partners, possibly 
generating Alx or Prx specific dimers. Structurally, Alx3, Alx4 and Cart1, the "Alx" proteins, 
form one subgroup and Prx1 and Prx2, the "Prx" proteins, another based on conserved 
similarities both within and outside the homeodomain. Therefore, the specificity and/or 
affinities of target binding and the dimerisation characteristics may differ only slightly but 
result in significant differences in affinity among Alx proteins and Prx proteins. This implies 
that the concentration of available members of the Alx and Prx proteins in a certain tissue and 
the presence or absence of dimerising partners determine the predominant dimer composition 
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and consequently which target genes (Alx or Prx) and developmental programs are controlled 
(see Table 1). Obviously, large overlap will exist among Alx and Prx target genes. How can we 
connect this to craniofacial development? In the frontonasal and nasal processes, Alx3, Alx4 
and Cart1 are expressed at higher levels than Prx1 and Prx2. Therefore, the homo- and 
heterodimers mostly consist of Alx3, Alx4 and Cart1 and Alx-specific dimerising cofactors in 
these structures, which predominantly control their morphogenesis. On the other hand, Prx1 
and Prx2 have more profound effects on the development of more posterior craniofacial 
regions, like the mandibular process of the first arch and the second arch.  
 
The Prx domain and the "Alx residues" 
Another molecular characteristic, which may create important functional divergence of Alx and 
Prx proteins, is the exclusive presence of the Prx domain in Prx1 and Prx2 (see Table 1). This 
domain has transcriptional activity in vitro. In Prx1 the Prx domain was reported to repress 
transcriptional activity. In Prx2 it can function both as a repressor and as an activator of 
transcription, dependent on the cell type used (Norris and Kern, 2001a,b). In vivo, this context 
could include cofactors present in cells of embryonic structure or regulation of the promoter to 
which Prx2 binds (Norris and Kern, 2001b). A number of dispersed highly conserved residues 
in between the homeodomain and aristaless domain are present in Alx3, Alx4 and Cart1, but 
not in Prx1, Prx2 and Prx3 (see Table 1). The function of these residues is unknown, but they 
may be involved in transcriptional regulation.  
 
Transcription regulatory domains  
Transcriptional regulation of a protein depends on the presence of transcriptionally active 
domains and on the sum of their activities. A number of transcription activation domains have 
been identified in the N-terminal tail and C-terminal tails of Prx1 and Prx2  (Norris and Kern, 
2001a,b). As already discussed in the previous sections, their Prx domains and aristaless 
domains also strongly affect transcriptional regulation in vitro (Norris and Kern, 2001a,b). In 
Alx4 two regions with transactivational potential were identified. One is located in between the 
homeodomain and the aristaless domain and encodes a relatively high number of proline 
residues and the other is located in the N-terminus (Hudson et al., 1998). In Alx3 and Cart1 no 
transregulatory domains have been identified to date.  
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We compared the transcriptional capacity of Alx3, Alx4, Cart1, Prx1 and Prx2 in p19EC cells 
and found significant differences. Alx3, Alx4 and Prx1 appeared in this cell line to be 
relatively strong activators of reporter gene transcription, whereas Cart1 and Prx2 activated 
transcription significantly less (See table 1; preliminary results, Wiegerinck and Brouwer). As 
shown by Norris and Kern, the in vitro transcriptional activity of Prx1 and Prx2 varies in two 
tested cell lines. Prx1 appeared to activate reporter gene transcription significantly stronger in 
NIH3T3 cells than in C2C12 cells, whereas transcription activation by Prx2 was similar in both 
cell lines (Norris and Kern, 2001a,b). Probably their transcriptional activity is dependent on the 
presence of interacting cofactors. This obviously has important consequences for how in vivo 
group-I aristaless-related proteins regulate expression of downstream target genes.   
In summary it becomes clear that functional heterogeneity of group-I aristaless-related proteins 
may arise by their differing transcriptional activities, which seems to depend on the presence or 
absence of cofactors. 
 
Summary 
Despite the fact that group-I aristaless-related genes are very similar, they nonetheless have 
different impacts on developmental processes that they control. Moreover, they also carry out 
divergent functions during embryogenesis. This functional heterogeneity obviously relies on 
differences in expression patterns. In addition, it may depend on differences in the regulation of 
target genes and downstream regulatory networks. Target gene regulation depends on a number 
of molecular and in vitro characteristics. Differences in these characteristics are likely to 
underlie the diversity in function during development (see Table 1). Most importantly, 
aristaless-related proteins are capable of interacting with cofactors in vitro. This very likely 
interferes with DNA binding and transcriptional activity of target genes in vivo. Aristaless-
related proteins have a number of conserved interaction domains. Their homeodomains are 
capable of forming homo- and heterodimers and their aristaless domains interfere with DNA 
binding and transcriptional regulation via intra- and intermolecular interactions. Also other 
conserved domains or residues may be involved in cofactor binding. As described in the 
previous sections important differences in characteristics of these interaction domains exist that 
are likely to underlie the functional heterogeneity among group-I aristaless related proteins. 
Secondly, target gene regulation depends on the organisation of the homeodomains of group-I 
aristaless-related proteins and on the concentration of proteins present in a certain cell type. 
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Probably the Prx homeodomains bind with high affinity to slightly different target sequences 
than Alx homeodomains, which results in functional divergence between Alx and Prx proteins. 
Thirdly, target gene regulation depends on the magnitude of transcriptional activity, which 
significantly differs among aristaless-related proteins.  
Thus, functional heterogeneity of group-I aristaless-related genes might arise through 
differences in their expression patterns and concentrations in embryonic tissues. In addition, 
this could also be explained by differences in cofactor-binding characteristics, transcriptional 
activities, dimerising properties and target gene binding specificities. 
 
Table 1:  Heterogeneity of group-I aristaless-related proteins by divergent molecular properties 
Protein 
(splice variant) 
Target genes 
(Alx or Prx) 
Aristaless 
domain 
Prx 
domain 
Alx 
residues 
Transcriptional activity 
in p19EC cells 
Alx3 Alx Divergent - + + 
Alx4 Alx Normal - + + 
Cart1 Alx Normal - + +/- 
Prx1a Prx Normal + - + 
Prx1b Prx Absent + - - 
Prx2 Prx Normal + - +/- 
 
Evolutionary conservation of function and molecular interactions  
Aristaless-related genes are found in animals belonging to a variety of phyla, including 
nematodes, cnidaria, arthropoda and chordata including all classes of vertebrates.  From 
expression and functional studies of these genes in Drosophila melanogaster (e.g. Schneitz et 
al., 1993; Campbell and Tomlinson, 1998), Hydra vulgaris (Gauchat et al., 1998; Smith et al., 
2000) and mice (see this thesis and references herein) it emerges that aristaless-related genes 
are generally linked to roles in proximo-distal patterning of structures protruding from the main 
body axis. Examples for such structures range from the tentacles of Hydra vulgaris (Smith et 
al., 2000) to all appendages of Drosophila and their imaginal discs (Schneitz et al. 1993; 
Campbell and Tomlinson 1998) and protruding structures in mouse embryos including facial 
and branchial processes, limbs and genital tubercles (see Meijlink et al., 1999).  Panganiban et 
al. have published evidence for a general link between distal-less (dll) related genes and 
proximo-distal patterning in a variety of non-homologous structures in organisms belonging to 
different phyla (Panganiban et al., 1995; Panganiban et al., 1997). While data on aristaless 
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genes are much less abundant than those on dll, it is striking that overlapping or 
complementary functions between dll and aristaless-related genes have been reported in 
different contexts like Drosophila appendages (Schneitz et al., 1993; Campbell and Tomlinson, 
1998) and mouse branchial arches (Ten Berge et al., 2001). It may well be that both types of 
homeobox genes are part of an evolutionary conserved regulatory circuit.  
 
Future experiments 
It has become clear from this chapter that group-I aristaless-related proteins carry out strongly 
overlapping functions during development of the craniofacial primordia and limb buds. 
However, they also possess distinct functions, which may rely on small differences in the 
molecular properties of their conserved domains. No in vivo evidence exists supporting this 
hypothesis, but it could be tested by knock-in studies. If knocking-in a highly related gene into 
the mutant locus of another gene results in complete rescue of the mutant phenotype, this 
would indicate that the inserted gene can completely compensate for function of the mutant 
gene. This would imply that molecular differences in their protein domains cannot account for 
the differences in function. In contrast, incomplete rescue of the mutant phenotype would 
strongly suggest that the differences in molecular characteristics do underlie the differences in 
function.  An important next step in studying group-I aristaless-related genes would be the 
identification of the relevant regulatory networks. Currently, we study the promoter regions of 
a number of aristaless-related genes. Hopefully this will lead to the identification of important 
regulatory sites and to factors that bind to these sites. To identify downstream regulatory 
networks of group-I aristaless-related genes, we currently apply the candidate gene approach. 
Expression of genes that are expressed in overlapping patterns and have similar functions 
during development of certain structures as the genes of interest is studied in mutant mice. 
Other ways to identify downstream regulatory genetic networks are RNA subtraction and/or 
screening of cDNA microarrays. These assays allow the identification of differentially 
expressed RNAs in selected control and mutant tissue. There are several methods to test 
relevance of the differentially expressed cDNAs. Currently, the method most applied is 
overexpression of these genes in mice or generation of mutant mice. However, electroporation 
of DNA into living in vitro cultured mouse and/or chick embryos or embryo structures is 
becoming an increasingly popular method to study gene function. Knock-out of gene function 
via RNAi may in future prove to be an applicable method in in vivo culture systems as well. 
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Summary 
 Aristaless-like proteins are Paired-type homeodomain proteins that lack the Paired domain, 
but have an additional conserved domain at the C-terminal end, the aristaless domain. Their 
name refers to the first known member of this protein subfamily. They are expressed in 
multiple embryonic tissues and are important for the proper development of these structures. 
On the basis of sequence similarities the genes encoding aristaless-like proteins can be further 
classified in three groups. Group-I genes are expressed predominantly in mesenchyme and 
mesoderm that is implicated in the morphogenesis of the skeleton and include Prx1, Prx2, 
Prx3 (Shox and Shot are two human homologs of Prx3), Alx3, Alx4 and Cart1. Group-II 
genes including Drg11, Arx, Chx10, Otp and Rx, are predominantly expressed in the central 
and/or peripheral nervous system and group-III genes including the Pitx1-3 encode K50 
homeodomain proteins. This thesis focuses on Alx3, Alx4 and Cart1 and their functions 
during development of the craniofacial skeleton, but also their roles during development of 
the limbs and the axial skeleton will be discussed. 
In Chapter 2 the embryonic expression patterns of group-I aristaless-related genes during 
critical stages of craniofacial and limb development are described. Alx3, Alx4 and Cart1 
appeared to be highly expressed in overlapping patterns in the frontonasal and nasal 
processes, distally in the mesenchyme of the first and second arches and in an anterior 
domain proximally in the outgrowing limbs. Prx1 and Prx2 are expressed at higher levels and 
in a broader region in the first and second branchial arches, but to lower levels in the 
frontonasal process and in the limbs they are highly expressed in a broad region along the 
limb margin. Expression of Prx3 overlaps that of the other five genes in craniofacial and limb 
regions, but has a significantly different character. These expression patterns suggest a further 
classification of the aristaless-related group-I genes in three subgroups: One consisting of 
Alx3, Alx4 and Cart1, another of Prx1 and Prx2 and the last of Prx3. This is in line with 
similarities in gene structure and with results from functional studies as far as available. 
Chapter 3 reports that mice that lack the aristaless-related homeobox gene Alx3 do not display 
anatomical abnormalities or diminished health. Analysis of Alx3/Alx4 double mutant mice 
showed that in Alx3 mutant mice, loss of Alx3 is compensated by Alx4. Alx4 loss-of-function 
mutants, including Strong’s luxoid mutants and Alx4 targeted knockouts, have a complex 
phenotype including preaxial polydactyly, and mild abnormalities in the skull. Mice double 
mutant for Alx3 and Alx4 had severe abnormalities in the skull that are not seen in Alx4 
mutants, although other aspects of the Alx4 phenotype were at the most marginally 
aggravated. Alx3/Alx4lst-J double mutants have severe clefting of the nose region. The earliest 
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signs of anatomical abnormalities in the head region became apparent around gestational day 
10.5, when the nasal processes grew out abnormally laterally. This resulted in failure of 
fusion of the nasal processes and ultimately in the cleft nose phenotype in newborn mice. 
Analyses of cellular parameters in early double mutant embryos demonstrated increased cell 
death in restricted regions of the presumptive nasal processes, which is most likely causally 
linked to the subsequent abnormal morphogenesis of the nasal processes.  
In Chapter 4 the skeletal phenotypes of Alx3/Cart1 double and Alx3/Alx4/Cart1 triple mutant 
mice are discussed. As expected, Alx3/Cart1 double mutants and Alx3/Alx4/Cart1 triple 
mutants display many defects similar to those of Alx3/Alx4 and Alx4/Cart1 double mutant 
mice in craniofacial and limb regions. In addition, also defects were found in Cart1 single 
mutants, which had not been reported before as well as unexpected defects in the craniofacial, 
appendicular and ribcage skeleton of Alx3/Cart1 double and Alx3/Alx4/Cart1 triple mutants. 
The results clearly show that Alx3, Alx4 and Cart1 have overlapping roles in patterning the 
craniofacial, appendicular and axial skeleton and that the contributions of each of the genes to 
the patterning processes differ in magnitude. These results underscore the importance of 
studying the phenotypes of compound mutants to fully explore the functions of highly related 
genes. 
Chapter 5 elaborates on the fact that despite that group-I aristaless-related proteins are very 
similar, they nonetheless have different impacts on several developmental processes and they 
also carry out divergent functions during embryogenesis. With the help of their molecular 
characteristics an attempt is made to explain this functional heterogeneity with differences in 
expression patterns and concentrations in embryonic tissues or on differences in cofactor-
binding characteristics, transcriptional activities, dimerising properties and target gene 
binding specificities. Moreover, it is discussed that the expression patterns and functions of 
aristaless-related genes seem to be evolutionary conserved, and the chapter is concluded with 
some suggestions for future research. 
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Samenvatting 
Aristaless-achtige eiwitten zijn Paired-type homeodomein eiwitten die geen Paired-domein 
hebben, maar wel een ander geconserveerd domein aan het C-terminale uiteinde van het 
eiwit, het aristaless domein. Hun naam verwijst naar het eerst bekende lid van deze 
eiwitfamilie. Ze komen tot expressie in diverse embryonale weefsels en zijn belangrijk voor 
de juiste ontwikkeling van deze structuren. Op basis van sequentieovereenkomsten kunnen de 
genen die voor de aristaless-achtige eiwitten coderen in drie groepen verder worden 
geclassificeerd. Groep-I genen komen hoofdzakelijk tot expressie in mesenchym en 
mesoderm dat betrokken is bij de morfogenese van het skelet. Deze groep bestaat uit Prx1, 
Prx2, Prx3  (Shox en Shot zijn twee humane Prx3 -homologen), Alx3, Alx4 en Cart1. Groep-
II bestaat uit Drg11, Arx, Chx10, Otp en Rx, die tot expressie komen in met name het centraal 
en/of het perifeer zenuwstelsel. Groep-III bestaat uit de genen Pitx1-3, die coderen voor K50 
homeodomein eiwitten. Dit proefschrift beperkt zich tot hoofdzakelijk Alx3, Alx4 en Cart1 en 
hun functies gedurende de ontwikkeling van het craniofaciale skelet, maar daarnaast wordt 
ook hun functie tijdens de ontwikkeling van de poot en het axiale skelet belicht. 
In Hoofdstuk 2 worden de embryonale expressiepatronen beschreven van groep-I aristaless-
achtige genen tijdens kritische stadia voor craniofaciale ontwikkeling en pootontwikkeling. 
Alx3, Alx4 en Cart1 komen op overlappende wijze tot expressie in het frontonasale proces en 
in de neusprocessen, distaal in het mesenchym van de eerste en tweede kieuwboog en in een 
anterieur domein proximaal in de uitgroeiende poten. Prx1 en Prx2 komen in de eerste en 
tweede kieuwboog sterker en in een groter gebied tot expressie, maar in het frontonasale 
proces komen ze lager tot expressie. In de poten komen ze in een groot gebied aan de rand 
van de poot hoog tot expressie. In craniofaciale en pootregionen overlapt het Prx3 
expressiepatroon die van de andere vijf genen, maar het verschilt wel aanzienlijk van 
karakter. Deze expressiepatronen suggereren een verdere sub-classificatie van aristaless-
achtige groep-I genen in drie subgroepen: Eén bestaande uit Alx3, Alx4 en Cart1, de andere 
uit Prx1 en Prx2 en de derde uit Prx3. Dit stemt overeen met de overeenkomsten in 
genstructuur en met de resultaten van functionele studies voor zover beschikbaar. 
In Hoofdstuk 3 wordt besproken dat muizen die het aristaless-achtige homeobox gen Alx3 
missen, geen anatomische afwijkingen of een verminderde gezondheid hebben. Analyse van 
Alx3/Alx4 dubbel mutante muizen liet zien dat in Alx3 mutanten het afwezig zijn van Alx3 
gecompenseerd wordt door Alx4. Alx4 "loss-of-function" mutanten, zoals Strong’s Luxoid  
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mutanten en getargete Alx4 mutanten, hebben een complex fenotype, waaronder preaxiale 
polydactyly en milde afwijkingen in de schedel. Muizen met mutaties in zowel Alx3 en Alx4 
hadden ernstige afwijkingen in de schedel, die afwezig zijn in Alx4 mutanten. Andere 
aspecten van het Alx4 fenotype daarentegen, waren hoogstens marginaal verergerd. 
Alx3/Alx4lst-J dubbel mutanten hebben ernstig gespleten neusgebieden. De eerste tekenen van 
anatomische afwijkingen in het kopgebied werden zichtbaar rond embryonale 
ontwikkelingsdag 10.5, wanneer de neusprocessen abnormaal ver naar laterale zijde 
uitgroeien. Dit resulteert in een fusiedefect van de neusprocessen en uiteindelijk in het 
gespleten neusfenotype van pasgeboren muizen. Analyse van cellulaire parameters in vroege 
dubbel mutante embryo’s toonde in een klein gebied binnen de zich ontwikkelende 
neusprocessen een toename van celdood aan. Hoogst waarschijnlijk kan dit causaal worden 
gekoppeld aan het abnormale verdere verloop van de morfogenese van de nasale processen.  
In Hoofdstuk 4 worden de skeletafwijkingen van Alx3/Cart1 dubbel en Alx3/Alx4/Cart1 
trippel mutante muizen besproken. Zoals verwacht hebben Alx3/Cart1 dubbel mutanten en 
Alx3/Alx4/Cart1 trippel mutanten veel defecten in craniofaciale en pootgebieden die lijken op 
die van Alx3/Alx4 en Alx4/Cart1 dubbel mutante muizen. Daarnaast werden afwijkingen 
gevonden in Cart1 mutante muizen, die niet eerder beschreven zijn en onverwachte 
afwijkingen in het craniofaciale en het ledematenskelet en in de ribbenkast van Alx3/Cart1 
dubbel mutanten en Alx3/Alx4/Cart1 trippel mutanten. Deze resultaten tonen duidelijk aan dat 
Alx3, Alx4 en Cart1 overlappende functies hebben tijdens de vorming van het craniofaciale en 
ledematenskelet en van de ribbenkast en dat de bijdrage van elk van de genen tot de 
vormingsprocessen verschilt in grootte. Deze resultaten benadrukken het belang van het 
bestuderen van de fenotypes van samengestelde mutanten met als doel het onderzoeken van 
functies van sterk verwante genen. 
In Hoofdstuk 5, wordt het feit belicht dat terwijl groep-I aristaless-achtige eiwitten heel erg 
op elkaar lijken, ze desondanks een verschillende mate van invloed kunnen hebben op de 
verschillende ontwikkelingsprocessen en dat ze daarnaast ook nog divergente functies kunnen 
uitoefenen tijdens de embryogenese. Aan de hand van moleculaire karakteristieken wordt  een 
poging gedaan deze functionele heterogeniciteit te verklaren met behulp van verschillen in 
expressiepatronen en concentraties van de eiwitten in embryonale weefsels of door 
verschillen in cofactorbindingskarakteristieken, transcriptionele activiteiten, 
dimerizeringseigenschappen en targetgenbindingsspecificiteiten. Daarnaast wordt het feit 
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behandeld dat expressiepatronen en functies van aristaless-achtige genen evolutionair 
geconserveerd lijken te zijn en besloten wordt met enkele suggesties voor toekomstig 
onderzoek.  
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Fig. 2.1: Expression of Alx3, Alx4, Cart1, Prx1-3 in whole mount E9.5 to E11.0 mouse embryos. 
First column shows semilateral views on E9.5 embryos, second column shows lateral views on E10.5 
embryos, Third column shows frontal views on E10.5 embryos and the fourth column shows frontal 
views on E11.0 embryos. Subsequent rows show expression patterns of Alx3, Alx4, Cart1, Prx1, Prx2
and Prx3, respectively. Diagrams illustrate crucial structures during craniofacial development in E9.5 
and E10.5 mouse embryos. Caudal ends of E10.5 and E11.0 embryos were removed to allow free 
view on craniofacial regions. Arrows in A, E and I point towards expression of Alx3, Alx4 and Cart1, 
respectively, in mesenchyme underlying nasal placodes. Arrows in F and J show expression of Alx4
and Cart1, respectively, in the maxillary process. Arrows in N and R point towards expression of 
Prx1 and Prx2, respectively, in the nasal processes. Arrowhead in N and R point towards expression 
of Prx1 and Prx2, respectively, in otocyst. Circles in L and S and T show region of nasal process 
mesenchyme from which expression of Cart1 and Prx2, respectively, is excluded. Staining in dorsal 
regions of the hindbrain as observed in D should be considered as an artefact. Note expression of 
Prx3 in mesencephalon in panel V and trigeminal and facio-acoustic complex in panel X. 
Abbreviations: FNP: frontonasal process; He: heart; LNP: lateral nasal process; Mn: mandibular 
arch; MNP: medial nasal process; Mx: maxillary process; O: otocyst; St: stomodeum; 2nd: 2nd
branchial arch. 
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Fig. 2.2: Expression of Alx3, Alx4 and Cart1 in nearby serial transversal sections of E9.5 and E10.5 
mouse embryos. The first three columns show expression of Alx3, Alx4 and Cart1, respectively. The 
fourth column shows sections with locations of important structures. In the fifth column the red line 
shows the approximate plane of sectioning. The subsequent rows show nearby sections through E9.5 
frontonasal process (A-E), E9.5 forelimb bud (F-J), E10.5 facial processes (K-O) and E10.5 forelimb 
bud (P-T). Arrows in I and S show approximate antero-posterior polarity of section. Abbreviations: 
BA: mandibular arch; FL: forelimb; FNP: frontonasal process; HL: hindlimb; LNP: lateral nasal 
process; Mx, maxillary process. 
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Fig. 2.3: (A-X) 
Expression of Alx3, 
Alx4, Cart1, Prx1-3 in 
E9.5 and E10.5 whole 
mount mouse fore- and 
hindlimbs. Subsequent 
columns show 
expression patterns of 
Alx3, Alx4, Cart1, Prx1-
3, respectively. First 
row shows E9.5 
presumptive hindlimb 
buds, second row shows 
expression in E9.5 
forelimb buds; third row 
shows expression in 
E10.5 hindlimb buds 
and the fourth row 
shows expression in 
E10.5 forelimb buds. 
Brackets in first row 
delineate region of 
presumptive hindlimb 
bud. Note expression of 
Prx3 in dorsal root 
ganglia in panel X. 
(Y) Diagrams showing 
summary of expression 
data in limbs. 
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Prx1 Prx1 Orientation Fig. 2.4: Expression of Prx1 
(A,D) and Prx2 (B,E) in 
nearby serial transversal 
sections of E12.5 (A,B) and 
E14.5 (D,E) mouse embryo 
forelimbs. Asterisks in A and 
B are positioned in 
mesenchymal condensations of 
the forelimb zeugopod. 
Arrows in D and E point 
towards expression of Prx1 
and Prx2, respectively, in the 
perichondrium of the forelimb 
zeugopod. The red lines in the 
diagrams in C and F show the 
approximate plane of 
sectioning. Abbreviations: D: 
digits; E: elbow joint 
condensation; S: stylopod 
condensation; Z: zeugopod 
condensation. 
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Fig. 3.1. Targeted mutagenesis of Alx3. (A) Structure of the Alx3 locus: Exon 2, 3 and 4 are depicted 
by open rectangles. The homeobox and the aristaless-box (encoding the aristaless/OAR domain) are 
shaded. (B) Targeting vector: A 6 kb LacZ-loxP-pGK-TKNEOpA-loxP cassette was inserted in
sequences of exon 2 upstream of the homeobox. 5’ 1.9 and 3’ 5.5 homologous sequences are 
indicated. Arrows in cassette indicate direction of transcription. (C) Targeted allele. The NcoI-XhoI 
probe corresponds to a region not present in the targeting construct, whereas the SstI-StuI probe 
detects the short homology arm. Relevant restriction sites and probes are indicated. Restriction 
fragments for Southern analysis are indicated with striped arrows above wildtype Alx3 allele and 
under targeted Alx3 allele. Coloured boxes: black, probes; red, loxP sites; blue, LacZ cassette; yellow, 
pGK-TKNEOpA cassette; green, homeobox; pink, aristaless-box. Restriction sites: N, NcoI; P, PstI; 
Sa, SalI; RI, EcoRI; S, StuI; B, BamHI. 
Fig. 3.2: Essentially correct Alx3/LacZ 
expression in knock-in mice; comparative 
expression analysis of Alx3 and Alx4 in 
E10.5 embryos. (A) Detection of Alx3
mRNA (whole mount in situ hybridisation) 
in whole embryo. (B) LacZ expression in 
Alx3+/- mouse embryo. Expression of Alx3
and LacZ are qualitatively identical, 
confirming proper targeting of the Alx3
locus. Staining in brain vesicles in panel A 
is background staining. (C,D) Radioactive 
in situ hybridisation showing overlapping 
expression of Alx3 and Alx4 in frontonasal 
processes (FNP) at E9.5. (G,H) Expression 
of Alx3 and Alx4 in medial nasal process 
(MNP) and mandibular arch (BA) at E10.5. 
(E,I) schemes indicating approximate 
orientation of sections. (F,J) Whole mount 
in situ hybridisation of E10.5 embryos 
showing overlap of expression in cranium 
and anterior mesenchyme of limbs.  
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Fig. 3.3: Forelimb and pectoral girdle defects in Alx mutants. Alizarin red (bone) Alcian blue 
(cartilage) stained forelimbs and pectoral girdles. Genotypes: (A,D) Alx3+/-/Alx4+/+; (B,E) 
Alx3+/+/Alx4lst-J/lst-J; (C,F) Alx3-/-/Alx4lst-J/lst-J. Arrowheads point towards the clavicle and arrows point 
towards (normal position of) deltoid crest. Asterisk marks extra digit in B and C. (D-F), dissected 
clavicles; double arrows and L-M indicate Lateral-Medial orientation of the clavicles. 
 
Control Alx3 +/+ /Alx4 -/- Alx3 +/- /Alx4 -/- Alx3 -/- /Alx4 -/- 
Fig. 3.4. Cranial phenotype of newborn Alx3/Alx4lst-J double mutant mouse. Lateral (A-D) and frontal 
(E-H) views on crania of Alx3+/- (A,E), Alx4lst-J/lst-J (B,F), Alx3+/-/Alx4lst-J/lst-J (C,G) and Alx3-/-/Alx4lst-
J/lst-J
 (D,H) newborn mice. The anterior region is truncated, the nose is split and the eyes are open. 
Note abnormal appearance of skull vault due to reduced parietal frontal and nasal bones in D. The 
severity of the cleft nose phenotype is highly variable. 
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Fig. 3.5. Craniofacial abnormalities in Alx3/Alx4lst-J double mutant newborn mice. Alizarin red 
(bone)/Alcian blue (cartilage) stained skulls are shown. First column shows a dorsal view on the 
vaults of the skulls. Second column shows dorsal views on skulls from which vaults were dissected. 
Third column shows a ventral view on skulls from which mandibles were dissected. Fourth column 
shows the dissected mandibles. Genotypes are indicated to the left. Green arrows point towards the 
basipresphenoid, which constitutes the border of neural crest derived skeletal elements and cephalic 
and somitic mesoderm derived skeletal elements. White arrows point towards nasal septum. 
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Fig. 3.6. Craniofacial abnormalities in Alx3-/-/Alx4lst-J/lst-J double mutant newborn mice. Photos and 
corresponding diagrams of control and Alx3/Alx4lst-J double mutant skulls. Upper half shows dorsal 
view on vaults of control (A,B) and Alx3/Alx4lst-J double mutant (C,D) skulls. Lower half shows 
ventral views on skulls from which mandible was dissected of control (E,F) and Alx3/Alx4lst-J  double 
mutant (G,H) mice. All skeletal elements are represented by a colour in the diagrams as indicated in 
the legend. Asterisks in E and G indicate positions of pterygoid processes. Abbreviations: As, 
alisphenoid bone; Bo, basioccipital bone; Bs, basisphenoid bone; M, maxilla; Ns, nasal septum; P, 
palatine; Ps, basipresphenoid bone; S, squamosal bone; So, supraoccipital bone. 
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Fig. 3.7. Histological analysis of cranial phenotype. Transversal sections of wildtype (A,C,E,G) and 
Alx3-/-/Alx4lst-J/lst-J (B,D,F,H) embryos. Stage (embryonic day) is indicated in left lower corner. 
Asterisks, nasal septum precartilage condensation; arrows, nasal cavity; arrow heads, Jacobson’s 
(vomeronasal) organ. Schemes below, with stages indicated, show approximate plane of section. 
Abbreviations, ps, palatal shelves, to, tongue. 
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Fig. 3.8. Aetiology of the split nose phenotype. The nasal processes of Alx3/Alx4lst-J double mutant 
embryos fail to fuse around E11.5. Shown are frontal views on control (A-D; either Alx3+/- or 
wildtype) and stage-matched Alx3/Alx4lst-J double mutant embryos (E-H) of E10.5 to E11.5 as 
indicated above photos. Posterior regions of most of the embryos were cut off to allow free view on 
the nasal processes. In the embryos of E11.5 the Alx3 expression domain was visualised by X-gal 
   
	
-galactosidase. Arrowheads point to medial edges of the medial nasal processes, 
demonstrating the improper outgrowth and fusion of the nasal processes in double mutant embryos. 
Note the increasing difference in distance between the processes of control and Alx3/Alx4lst-J double 
mutant embryos. 
 
Colour figures 
 121 
P
a
x9
 
P
rx3
 
co
n
tr
o
l 
co
n
tr
o
l 
Fgf8
 
Shh
 
Fig. 3.9. Study of phenotype 
by analysis of expression 
patterns of marker genes in 
serial sections. Probes used 
are specified to the right of 
the Figure. Panels A, E, G-I, 
M-O are control embryos 
(either Alx3 heterozygotes or 
wildtype) panels B, C, F, J-L, 
P-R are Alx3-/-Alx4lst-J/lst-J. 
Panels A-F show serial 
sections of two E10.5 
embryos and expression of 
ectodermal markers, where D 
is a scheme to indicate 
approximate plane of sections 
in the embryos used in this 
experiment. Panels G-R show 
nearby serial sections of two 
control and two double 
mutant embryos and 
expression of two 
mesenchymal markers. Panels 
G, J, M, N show E10.5 
embryos; H, I, K, L, N, O, Q, 
R show rather advanced 
E11.5 embryos. Orientation of 
sections of this series of 
embryos is depicted in lower 
row of panels. Arrows (in A-
C) indicate Shh expression in 
ectoderm of the medial nasal 
processes. Abbreviations: BA, 
branchial (mandibular) arch; 
FB, forebrain; FNP 
frontonasal process; HE, 
heart; HB, hindbrain; Man, 
max, mandibular and 
maxillary process, 
respectively, of first branchial 
arch; MNP, medial nasal 
process; MP, maxillary 
process; NC, nasal cavity; NS, 
nasal septum; O, otocyst; PS, 
palatal shelf (part of maxilla); 
To, tongue. 
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     Control 
Fig. 3.10: Apoptosis in Alx3/Alx4lst-J double mutant embryos. In a restricted region of the frontonasal 
process of Alx3/Alx4lst-J double mutant embryos a significant number of mesenchymal cells undergo 
apoptosis compared to stage matched control embryos. Panels A,D, F, H, K represent control 
embryos (wildtype or Alx3+/- ); panels B,E,G,I,L represent embryos of double mutant embryos; 
panels C,J,M are schemes depicting plane of sections of embryos shown to their left. TUNEL assays 
were done to detect apoptosis. Positive cells appear red in this assay, as seen in brightfield images 
(panels A,B,F,G). Because of difficulty with visualising TUNEL staining simultaneously with 
histology, we show also darkfield images where positive cells appear as white to orange spots. The 
yellow squares in panels D and E mark the crucial area where we found differences in apoptosis in 
E10.0 embryos. These areas are shown enlarged, and in brightfield, in panel G. No or very few 
apoptotic cells were detected in the vicinity of the nasal processes of embryos of E10.5 and E11.5. 
The yellow arrows in panels H and I point to apoptopic areas in the maxillary component of the first 
branchial arch, confirming that the negative result in this experiment was not due to technical failure. 
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Figure 4.1: Skeletal abnormalities in newborn skulls of Alx3/Cart1 double and Alx3/Alx4/Cart1
triple mutant mice. Genotypes are indicated in figure. First column shows dorsal views on the skulls; 
the second column shows dorsal views with vaults removed; the third column shows a ventral view 
with mandible removed and the fourth column shown dorsal view on dissected mandible.  
 
Colour figures 
 
124 
 
 
Control 
Alx3 +/+ /Cart1 -/- 
Alx3 -/- /Cart1 +/- 
Alx3 +/- /Cart1 -/- 
Alx3 -/- /Cart1 -/- 
forelimb +  
shoulder girdle 
hindlimb  
autopod 
Alx3 -/- /Cart1 -/- 
Alx3 +/- / Alx4 +/- / Cart1 +/- 
Alx3 -/- / Alx4 +/- / Cart1 +/- 
 
 
 
 
Figure 4.2: Limb 
abnormalities in Alx3/Cart1 
double and Alx3/Alx4/Cart1 
triple mutant mice. 
Genotypes are indicated in 
figure. Panels A, C, G, I, K, 
M show forelimbs with 
pectoral girdle attached, B, 
D, F, H, J, L and N show 
autopods of hindlimbs. 
Arrows in C, G and I point 
towards malformed scapula. 
Asterisks in F, H, J, L and N 
point towards extra digit. O 
and P show the postaxial 
protrusion on the forelimb 
of an Alx3-/-/Cart1-/- mouse. 
Asterisks in O indicate 
postaxial protrusion and 
arrow in P points towards 
cartilaginous nodule present 
at postaxial side of the 
forelimb autopod. 
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Alx3 -/- / Alx4 +/- / Cart1 +/- Control Figure 4.4: Skeletal abnormalities in 
Alx3/Alx4/Cart1 triple mutant mice. Genotypes are 
indicated in figure. Panel A and B show dorsal 
views on the ribcages of control and triple newborn 
mutants, respectively. Asterisks in B mark abnormal 
thirteenth rib. C and D show ventral views on pelvic 
girdle of control and triple mutant newborn mouse, 
respectively. Asterisks in D mark truncated pubic 
bone. E and F show hindlimb zeugo- and autopods 
of control and triple mutant newborn mouse, 
respectively. Arrow in F point towards malformed 
tibia. 
 
 
Figure 4.3: Rib cage abnormalities in Alx3/Cart1 double and 
Alx3/Alx4/Cart1 triple mutant mice. Genotypes are indicated in 
figure. Arrows point towards xyphoid process of the sternum. 
Asterisks in B and D mark protrusions at the xyphoid process of 
the sternum. White arrowhead point towards point of fusion of 
two ribs. 
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Dankwoord 
Ook ik heb nooit durven dromen dat het ooit zover zou komen. Maar daar is hij dan toch. 
Dagen, weken, maanden, jaren ploeteren, maar met succes. En ik ben trots. Niet alleen op 
mezelf. Ook nog op nog heel veel andere mensen. Gelukkig ben ik in de gelegenheid iedereen 
hiervoor op deze plek te bedanken. Als eerste wil ik natuurlijk Frits bedanken. Jij hebt elke 
minuut van mijn OIO bestaan in volle glorie meegemaakt. Zeker in het begin was het wel 
eens moeilijk. Ik heb eerst volwassen moeten worden en jij hebt moeten wennen aan mijn 
nogal onstuimige manier van aanpak. Maar met heel veel plezier kijk ik terug op met name 
het laatste moeilijke spannende jaar. Er is erg veel gebeurd en ik heb ontzettend veel steun 
van je gehad. Een greep: artikelen en proefschrift schrijven en publiceren, verlenging 
aanvragen, EMBO fellowship aanvragen, en tot slot promoveren. Heel erg bedankt! Door alle 
tegenslag zag het er even ernstig naar uit dat ik wetenschap zou inruilen voor 
wetenschapsjournalistiek. Maar ik ben zo blij te merken dat ik weer vol zin en enthousiasme 
uitkijk naar mijn post-doc periode in Genua! En wat ik helemaal fantastisch vind is dat we 
min of meer blijven samenwerken aan aristaless in combinatie met Distalless. And Rolf. I am 
the first graduate student that under your supervision will get her Ph.D.!! I want to thank you 
as well for your efforts to arrange extra time to finish my thesis. I will never forget our phone 
call last summer when I told you that I was applying for a job abroad. Your reaction was so 
enthusiastic! It took immediately away all my doubts. Thank you for your help during the last 
phase of the promotion and with the fellowship application. En natuurlijk ben ik Christine 
Mummery ook heel erg dankbaar voor haar deelname in mijn begeleidingscommissie. Een 
vierdejaars OIO heeft strikt genomen niet zo veel meer aan zo’n commissie, maar ikke wel! 
Dank je voor al je steun! 
En dan mijn labmaatjes. Lieve lieve Ericson, wat een rare tijd en wat heerlijk dat je er was. Je 
onvoorwaardelijke vriendschap, je droge relativerende humor, je skeletkleurings- en TUNEL 
assay protocollen waar ik wel honderd keer om gevraagd heb. Alles heeft bijgedragen aan het 
feit dat het uiteindelijk gelukt is. Jij verder in de wetenschap en ik ook! En elkaars paranimf! 
Wie van ons had dat een paar jaar geleden durven denken? Dank je, dank je, dank je! Tony 
Cannelloni, wij samen Senior OIO, de jongere lichting beschouwend. Het was leuk en het 
was goed. Blijf vooral zo kritisch en slim. En kom alsjeblieft snel een keer echte Cannelloni´s 
eten in Genua, zou ik zo zeggen. Derkie, mijn aristaless voorganger. Ik heb fijn de kunst een 
beetje bij je kunnen afkijken. Bedankt voor al je wijze adviezen en raad, gij Groot Orakel! 
Moeder Antje, ons aller hoedster. Dankzij jou kreeg ik uiteindelijk mijn lang bevochten 
targeting construct en kan ik ES cellen kweken, in situs doen, proliferatie assays uitvoeren en 
nog heel veel meer. Dank je voor je inspanningen en vriendschap. En dat geldt voor immer 
goed geluimde Wimpie natuurlijk ook. En Carla die me onmisbaar heeft bijgestaan met name 
tijdens de laatste vreselijk spannende proeven voor het “Development” artikel! En natuurlijk 
Jeroentje R., hoe tekenend was jouw aanwezigheid voor mijn herinnering aan het lab-leven! 
Bernie. Nu aan het carrière maken in Boston, maar in Utrecht gingen we vaak leuk bandjes 
kijken. Bedankt ook voor alle hulp in het lab! Sylvie, nous n'avons que parlé l´anglais au 
laboratoire, mais on a joué au squash au dehors! Merci pour ta amitié et bonne chance en 
France! En onze recente aanwinsten Johanski en Sanne natuurlijk. Het was jammer genoeg 
erg kort. Heel veel succes met de komende jaren! En alle andere lab-maatjes: Jacqueline, 
Kirstie, Jeroen Charité, Isabel, Nathalie, Laura, Marjo en natuurlijk de Zeller-groep! Ook 
mogen mijn buitengroepse collega´s niet vergeten worden. Iedereen heel erg bedankt! Mijn 
student Geert Hamer: jammer, jammer, jammer, we hebben samen niet echt prachtige 
ontdekkingen gedaan. Maar waarschijnlijk daarom ben ik nu zo ontzettend trots op je 
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Oncogene artikel, bij elkaar gepipetteerd tijdens je AIO project! Vivienne kwam binnen 
tijdens de nogal hectische verhuizingperiode maar onverstoorbaar sloeg ze aan het pipetteren. 
En, jawel, daar krijg je een (toekomstig) co-auteurschap van!  
En dan hebben we op het Hubrecht van die heerlijke diensten die je een hele hoop werk uit 
handen nemen. Jeroen Korving. Wat heb ik je een hoop ellende gegeven met al mijn 
embryo’s die allemaal precies parallel gesneden moesten worden èn perfect transversaal èn 4 
PGLk èn over drie series glaasjes verdeeld èn ook nog RNase vrij alstublieft! Maar het is 
allemaal gelukt. Mark Reijnen, de muizenman. Zonder hem geen mutante muizen, transgeen 
of knock-out. Bert, Obbe, Irma en Truus, wat zijn jullie een lieverds, ook voor die lieve 
muisjes! Ferdi en Jaap: scannen, scannen, scannen en dia’s maken en KODAK prints. Alles 
werd even mooi! Kijk maar eens naar het kleurenkatern! De computerboys and girl. Prachtige 
3D reconstructies van mijn mooie LacZ mutante embryo’s! Helaas staan ze niet in dit boekje. 
Analyses van proliferatie assays, schedel diagrammen, CMYK proefschriftplaatjes, etc. en 
buiten het lab samen reizen en lekker eten! Patricia en Sander. Bedankt voor alle oplossingen 
en leut! Henk en Gerard, ook voor computeraangelegenheden. Mijn grote files zijn eindelijk 
definitief van het net. Richard en Romke voor aanvulling van alle nodige voorraden. Oeke 
voor de bibliotheek. En zo zijn er vast nog vele andere die ik nog niet heb genoemd, maar aan 
wie ik op zijn minst net zo veel dank ben verschuldigd. Heel heel erg bedankt! 
Buiten het lab. Klaartje, mijn tweede paranimf, wij tweetjes gaan al zo veel jaren mee en ik 
ben altijd zo ontzettend blij dat jij er bent! En ook strakjes aan de katheder. Goddank! En 
verder: Wendy, JW (prachtige cover!!), Peter Vogelaar, Noel, Miriam, Rowdy, Leonie, Arjen, 
Floriëlle, Xenia, Frenkel, Lennert, Sandra, Ynte, Ellemieke, Ruud, bedankt voor jullie 
onontbeerlijke vriendschap. Arjen, kom alsjeblieft nog zo vaak als je wilt op onverwachts 
bezoek, ook in Genua. Uit de begintijd wil ik met name Paul van Beukering en John 
Gundlach bedanken voor de heerlijke tijd die we hebben gehad. Verder ben ik al mijn andere 
vrienden en mijn familie heel erg dankbaar voor alle liefde en aandacht en steun. Ook de NS 
moet even genoemd worden. Zo’n 100000 km lang heeft de trein me tussen Amsterdam en 
Utrecht veilig heen en weer gereden. Dat kan niet zonder gevolg. Met Ramon heb ik menig 
ontzettend gezellige kilometer afgelegd. Ik zal het gaan missen! Rowdy ken ik uit de trein en 
eigenlijk Leonie dus ook. Maar wie mijn leven helemaal op de kop heeft gezet is natuurlijk 
Tjarco. Een jaar lang hebben we samen naar Utrecht gereisd, op vrijdagochtend, 8.24 uur, 
achterste treinstel onderin. Al bijna drie jaar ben je er altijd voor me en wat een boel 
vertrouwen en steun heb ik van je gehad! Het is heel goed voor mij geweest en ook heel goed 
voor mijn onderzoek. Hoe kan ik je daar ooit voor bedanken! En nu samen naar Genua! 
Spannend!
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